Unassociated Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 10-Q
 
(mark one)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended December 31, 2006
 
OR
 
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                      to                      
 
Commission File Number:
000-33477
 
GENESIS MICROCHIP INC.
(Exact name of registrant as specified in its charter)
 
DELAWARE
77-0584301
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
   
2150 GOLD STREET
P.O. BOX 2150
ALVISO, CALIFORNIA
95002
(Address of principal
executive offices)
(Zip Code)
(408) 262-6599
Registrant’s telephone number, including area code
 
N/A
Former name, former address and former fiscal year if
changed since last report.
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes  x    No  ¨ 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer x              Accelerated filer ¨                    Non-accelerated filer  ¨ 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):
 
Yes  ¨    No  x 
 
There were 37,038,624 shares of the registrant’s shares of common stock issued and outstanding as of January 31, 2007.
 




 

GENESIS MICROCHIP INC.
FORM 10-Q
THREE AND NINE MONTHS ENDED December 31, 2006
 
Index
 
 
Page 
Item Number
   
   
Part I: Financial Information
 
Item 1.
Financial Statements
 
 
Condensed Consolidated Balance Sheets at December 31, 2006 and March 31, 2006
3
 
Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2006 and December 31, 2005
4
 
Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2006 and December 31, 2005
5
 
Notes To Condensed Consolidated Financial Statements
6
     
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
18
     
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
30
     
Item 4.
Controls and Procedures
30
   
Part II: Other Information
 
     
Item 1.
Legal Proceedings
30
     
Item 1a.
Risk Factors
33
     
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
*
     
Item 3.
Defaults Upon Senior Securities
*
     
Item 4.
Submission of Matters to a Vote of Security Holders
*
     
Item 5.
Other Information
*
     
Item 6.
Exhibits
40
     
Signatures
 
44
 
* No information has been provided because this item is not applicable.

2

 
 
PART I: FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
 
GENESIS MICROCHIP INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share amounts)
           
 
 
December 31,
2006
(unaudited)
 
March 31,
2006 
 
     
 
       
ASSETS
         
Current assets:
         
Cash and cash equivalents
 
$
139,798
 
$
154,630
 
Short-term investments
   
53,879
   
30,749
 
Accounts receivable trade, net of allowance for doubtful accounts of $17 at December 31 and $401 at March 31
   
28,549
   
36,184
 
Inventories
   
17,968
   
17,175
 
Prepaids and other
   
6,957
   
6,034
 
Total current assets
   
247,151
   
244,772
 
Property and equipment, net
   
15,305
   
16,459
 
Intangible assets, net
   
4,654
   
9,055
 
Goodwill
   
84,405
   
181,981
 
Deferred income taxes
   
   
11,151
 
Other long-term assets
   
15,853
   
16,259
 
Total assets
 
$
367,368
 
$
479,677
 
 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY
         
Current liabilities:
         
Accounts payable
 
$
7,260
 
$
14,911
 
Accrued liabilities
   
22,690
   
21,778
 
Income taxes payable
   
6,357
   
3,565
 
Total current liabilities
   
36,307
   
40,254
 
Stockholders’ equity:
         
Capital stock:
         
Preferred stock:
         
Authorized 5,000 preferred shares, $0.001 par value
         
Issued and outstanding – none at December 31 and at March 31
         
Common stock:
         
Authorized – 100,000 shares of common stock, $0.001 par value
         
Issued and outstanding – 36,684 shares at December 31 and 35,899 shares at March 31
   
37
   
36
 
Additional paid-in capital
   
457,984
   
441,197
 
Treasury shares
   
(833
)
 
 
Cumulative other comprehensive loss
   
(94
)
 
(94
)
Deferred stock-based compensation
   
   
(4,572
)
Retained earnings (deficit)
   
(126,033
)
 
2,856
 
Total stockholders’ equity
   
331,061
   
439,423
 
 
         
Total liabilities and stockholders’ equity
 
$
367,368
 
$
479,677
 
 
See accompanying notes to condensed consolidated financial statements.

3

 

GENESIS MICROCHIP INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(amounts in thousands, except per share amounts)
(unaudited)

   
Three Months Ended
 
Nine Months Ended
 
   
December 31
 
December 31
 
   
2006
 
2005
 
2006
 
2005
 
Revenues
 
$
51,117
 
$
73,965
 
$
176,025
 
$
208,644
 
Cost of revenues (1)(2)
   
30,261
   
39,762
   
101,726
   
117,355
 
Gross profit
   
20,856
   
34,203
   
74,299
   
91,289
 
                           
Operating expenses:
                         
Research and development (3)(5)
   
15,621
   
12,541
   
47,939
   
35,045
 
Selling, general and administrative (4)
   
19,786
   
12,195
   
49,922
   
35,040
 
Impairment of goodwill and intangibles
   
101,001
   
-
   
101,001
   
-
 
Total operating expenses
   
136,408
   
24,736
   
198,862
   
70,085
 
Income (loss) from operations
   
(115,552
)
 
9,467
   
(124,563
)
 
21,204
 
Interest and other income
                         
Interest income
   
2,324
   
1,519
   
6,700
   
3,496
 
Other income (6)
   
-
   
-
   
3,217
   
-
 
Interest and other income
   
2,324
   
1,519
   
9,917
   
3,496
 
Income (loss) before income taxes
   
(113,228
)
 
10,986
   
(114,646
)
 
24,700
 
Provision for income taxes (7)
   
17,209
   
3,621
   
14,243
   
5,993
 
Net income (loss)
 
$
(130,437
)
$
7,365
 
$
(128,889
)
$
18,707
 
                           
Earnings (loss) per share:
                         
Basic
 
$
(3.57
)
$
0.21
 
$
(3.55
)
$
0.54
 
Diluted
 
$
(3.57
)
$
0.20
 
$
(3.55
)
$
0.51
 
                           
Weighted average number of shares of common stock outstanding:
                         
Basic
   
36,585
   
35,413
   
36,342
   
34,632
 
Diluted
   
36,585
   
37,295
   
36,342
   
36,718
 
                           
(1) Amount includes amortization of acquired developed product technology
 
$
-
 
$
1,925
 
$
-
 
$
5,775
 
                           
(2) Amount includes stock-based compensation
 
$
289
 
$
27
 
$
1,088
 
$
27
 
                           
(3) Amount includes stock-based compensation
 
$
1,952
 
$
74
 
$
6,310
 
$
253
 
                           
(4) Amount includes stock-based compensation
 
$
2,267
 
$
260
 
$
7,569
 
$
372
 
                           
(5) Amount includes amortization of intangibles related to acquisitions
 
$
428
 
$
729
 
$
1,417
 
$
2,187
 
                           
(6) Gain on sale of investment
 
$
-
 
$
-
 
$
3,217
 
$
-
 
                           
(7) Amount includes deferred income tax asset valuation allowance in a certain jurisdiction
 
$
16,778
 
$
-
 
$
16,778
 
$
-
 
 
See accompanying notes to condensed consolidated financial statements.

4

 

GENESIS MICROCHIP INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)
(unaudited) 
 
   
Nine Months Ended
December 31
 
   
2006
 
2005
 
Cash flows from (used in) operating activities:
             
Net income (loss)
 
$
(128,889
)
$
18,707
 
Adjustments to reconcile net income (loss) to net cash from operating activities:
             
Depreciation and amortization
   
7,776
   
5,559
 
Amortization of acquired technology
   
1,988
   
7,962
 
Impairment of intangible assets
   
3,425
   
-
 
Goodwill impairment
   
97,576
   
-
 
Stock-based compensation
   
14,967
   
652
 
Deferred income taxes
   
11,151
   
3,818
 
Gain on sale of investment
   
(3,217
)
 
-
 
Other
   
250
   
453
 
Change in operating assets and liabilities, net of amounts acquired:
             
Accounts receivable trade
   
7,635
   
(6,935
)
Inventories
   
(793
)
 
(5,630
)
Prepaids and other
   
(923
)
 
(1,535
)
Accounts payable
   
(7,651
)
 
(1,780
)
Accrued liabilities
   
912
   
8,798
 
Income taxes payable
   
2,792
   
(560
)
 Net cash provided by operating activities
   
6,999
   
29,509
 
Cash flows from (used in) investing activities:
             
Purchase of short-term investments
   
(72,536
)
 
(71,733
)
Proceeds on maturity of short-term investments
   
49,406
   
10,002
 
Additions to property and equipment
   
(4,487
)
 
(6,705
)
Proceeds on sale of investment
   
3,919
   
-
 
Additions to mask sets
   
(2,413
)
 
(2,598
)
Additions to intangible assets
   
(1,280
)
 
(565
)
Other
   
-
   
287
 
 Net cash used in investing activities
   
(27,391
)
 
(71,312
)
Cash flows from financing activities:
       
Proceeds from issue of common stock
   
5,560
   
25,261
 
 Net cash provided by financing activities
   
5,560
   
25,261
 
               
Decrease in cash and cash equivalents
   
(14,832
)
 
(16,542
)
Cash and cash equivalents, beginning of period
   
154,630
   
129,757
 
Cash and cash equivalents, end of period
 
$
139,798
 
$
113,215
 
 
See accompanying notes to condensed consolidated financial statements.

 
5

 

GENESIS MICROCHIP INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
 
1. Basis of presentation
 
Genesis Microchip Inc. (“Genesis” or the “Company”) designs, develops and markets integrated circuits that manipulate and process digital video and graphic images.
 
We have prepared the accompanying unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”) and according to the rules and regulations of the Securities and Exchange Commission for interim financial reporting. Consequently, they do not include all of the information and footnotes required by GAAP for a complete set of annual financial statements. The policies applied are consistent with those at March 31, 2006, except as outlined in Note 2. These condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended March 31, 2006 that are included in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. We believe that the accompanying financial statements reflect all adjustments, consisting solely of normal, recurring adjustments, that are necessary for a fair presentation of the results for the interim periods presented. The results of operations for the three and nine months ended December 31, 2006 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period.
 
2. Stock-based compensation
 
On April 1, 2006, the Company adopted Statement of Financial Accounting Standards (“SFAS”) No. 123 (revised 2004), Share-Based Payment (“SFAS 123R”), which requires the measurement and recognition of compensation expense for all share-based payment awards based on the grant date fair value of the awards.
 
Prior to the adoption of SFAS 123R, the Company followed Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for Stock Issued to Employees” and related interpretations, in accounting for employee stock options and restricted stock units. Under APB 25, deferred stock-based compensation was recorded at the grant date in an amount equal to the excess of the market value of a share of common stock over the exercise price of the option or restricted stock unit and was amortized over the vesting period of the individual options or stock units, generally two to four years, in accordance with Financial Accounting Standards Board’s (“FASB”) Interpretation No. 44.
 
The Company adopted SFAS 123R using the modified prospective transition method, which requires the recognition of compensation expense for awards granted after April 1, 2006 that are expected to vest and for unvested awards granted prior to adoption that are expected to vest. The compensation expense related to the awards granted prior to adoption is based on the grant date fair value estimated in accordance with SFAS 123 for prior year pro forma disclosure purposes, adjusted to reflect estimated forfeitures. In accordance with the modified prospective transition method, prior period results have not been adjusted to reflect the adoption of SFAS 123R. No modifications were made to the terms of the Company’s outstanding stock options in anticipation of the adoption of SFAS 123R.
 
During the three and nine months ended December 31, 2006, the Company recognized stock-based compensation expense of $4,508,000 and $14,967,000, respectively, related to stock options, restricted share units and employee share purchase plans granted to employees and directors. The Company has not capitalized any stock-based compensation costs as part of the cost of an asset. There were no tax benefits recognized related to the compensation cost for share-based payments.
 
The cumulative effect of the implementation of SFAS 123R for the three months ended December 31, 2006 was to increase loss from operations, loss before income taxes and net loss by $3,889,000 and basic and fully diluted loss per share by $0.11. The cumulative effect of the implementation of SFAS 123R for the nine months ended December 31, 2006 was to increase loss from operations, loss before income taxes and net loss by $13,445,000 and basic and fully diluted loss per share by $0.37. In addition, $4,572,000 of deferred stock-based compensation recorded as a reduction to stockholder’s equity as of March 31, 2006 was reversed against the Company’s additional paid-in-capital. There was no impact on cash flows from operating and financing activities.

6

 

The fair value of stock-based compensation was determined using the Black-Scholes option-pricing model using a dividend yield of 0% and the assumptions noted in the following table:
  
   
Three Months Ended December 31
 
Nine Months Ended December 31
 
   
2006
 
2005
 
2006
 
2005
 
Stock Option Plans:
                         
Risk-free interest rates
   
4.7
%
 
4.3
%
 
4.9
%
 
4.3
%
Volatility
   
63
%
 
80
%
 
67
%
 
80
%
Expected life in years
   
4.25
   
4.25
   
4.25
   
4.25
 
                           
Employee Stock Purchase Plans:
                         
Risk-free interest rates
   
5.1
%
 
4.4
%
 
5.1
%
 
4.4
%
Volatility
   
47
%
 
80
%
 
47
%
 
80
%
Expected life in years
   
0.75
   
1.25
   
0.75
   
1.25
 
 
The Company uses historical volatility as a basis for projecting the expected volatility of the underlying stock and estimates the expected life of its stock options based upon historical data. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.
 
The weighted average grant date fair values of options granted during the three and nine months ended December 31, 2006, were $5.56 and $6.39, respectively. The weighted average grant date fair values of options granted during the three and nine months ended December 31, 2005 were $12.60 and $12.67 respectively.
 
In accordance with SFAS 123R, the Company is required to estimate the number of instruments for which the requisite service is expected to be rendered. Under APB 25, forfeiture rates were recognized as they occurred. The cumulative effect of the change in accounting policy for the adjustment related to the forfeitures for the prior periods was not material at April 1, 2006.
 
Had the Company accounted for stock-based compensation in accordance with SFAS 123R prior to April 1, 2006, our net earnings would have approximated the pro forma amount for the three and nine months ended December 31, 2005 as follows:
 
(in thousands, except per share amounts):
           
 
 
Three Months Ended
December 31, 2005
 
Nine Months Ended
December 31, 2005
 
Net income attributable to common stockholders:
           
As reported
 
$
7,365
 
$
18,707
 
Stock compensation, as reported
   
361
   
652
 
Stock compensation, under SFAS 123
   
(5,841
)
 
(17,110
)
Pro forma net income
 
$
1,885
 
$
2,249
 
 
         
Basic earnings per share:
         
As reported
 
$
0.21
 
$
0.54
 
Pro forma
 
$
0.05
 
$
0.06
 
Diluted earnings per share:
         
As reported
 
$
0.20
 
$
0.51
 
Pro forma
 
$
0.05
 
$
0.06
 
 
7

 
 
STOCK OPTION AND STOCK PURCHASE PLANS
 
1997 Employee Stock Option Plan
 
The 1997 Employee Stock Option Plan (“1997 Employee Plan”) provided for the granting to employees of incentive stock options, nonstatutory stock options, stock purchase rights and restricted stock units for up to 800,000 shares of common stock plus an annual increase to be added on the first day of each fiscal year equal to the lesser of (i) 2,000,000 shares of common stock, (ii) 3.5% of the outstanding shares on such date, or (iii) a lesser amount determined by the Board of Directors of Genesis. The exercise price of incentive stock options granted under the 1997 Employee Plan was not to be less than 100% (110% in case of any options granted to a person who held more than 10% of the total combined voting power of all classes of shares of Genesis) of the fair market value of the shares of common stock subject to the option on the date of the grant. The term of the options do not exceed 10 years (five years in the case of any options granted to a person who held more than 10% of the total combined voting power of all classes of shares of Genesis) and generally vest over four years.
 
As of December 31, 2006, there were 1,661,000 shares available for grant under the 1997 Employee Plan. In the quarter ended December 31, 2005, the Company amended the 1997 Employee Stock Option Plan to allow the granting of stock appreciation rights, stock purchase rights, and restricted stock units. The Company has not issued any stock appreciation rights or stock purchase rights to date. The term of restricted stock units is consistent with the vesting period and does not exceed 4 years.
 
1997 Paradise Stock Option Plan
 
The 1997 Paradise Stock Option Plan (“Paradise Plan”) provided for the granting of incentive stock options (“ISOs”) to employees of Paradise Electronics Inc. (“Paradise”), a wholly owned subsidiary of Genesis and nonstatutory stock options (“NSOs”) to Paradise employees, directors, and consultants. As a result of the merger of Paradise with Genesis in May 1999, each outstanding option or right to purchase shares of Paradise common stock became exercisable for Genesis shares of common stock, adjusted to reflect the exchange ratio of Genesis shares of common stock for Paradise common stock in the merger. No additional options will be granted under the Paradise Plan. Upon exercise, expiration or cancellation of all of the options granted under the Paradise Plan, this plan will be terminated.
 
1997 Non-Employee Stock Option Plan
 
The 1997 Non-Employee Stock Option Plan (“Non-Employee Plan”) provides for the granting to non-employee directors and consultants of Genesis of options for up to 500,000 shares of common stock. The exercise price of stock options granted under the Non-Employee Plan may not be less than 100% of the fair market value of the shares of common stock subject to the option on the date of the grant. Options granted under the Non-Employee Plan have a term of up to ten years and generally vest over periods of up to two years. As of December 31, 2006, there were 55,000 shares available for grant under the Non-Employee Plan.
 
2000 Nonstatutory Stock Option Plan
 
The 2000 Nonstatutory Stock Option Plan (“2000 Plan”) provides for the granting to employees and non-employees of nonstatutory stock options and stock appreciation rights for up to 1,500,000 shares of common stock plus an annual increase to be added on the first day of each fiscal year equal to the lesser of (i) 2,000,000 shares of common stock, (ii) 3.5% of the outstanding shares on such date, or (iii) a lesser amount determined by the Board of Directors of Genesis. The exercise price of stock options granted under the 2000 Plan may not be less than 100% of the fair market value of the shares of common stock subject to the option at the date of grant. The term of the options may not exceed 10 years and generally vest over four years. As of December 31, 2006, there were 1,362,000 shares available for grant under the 2000 Employee Plan. In the quarter ended December 31, 2005, the Company amended the 2000 Nonstatutory Stock Option Plan to allow the granting of stock appreciation rights. The Company has not issued any stock appreciation rights to date.
 
2001 Nonstatutory Stock Option Plan
 
The 2001 Nonstatutory Stock Option Plan (“2001 Employee Plan”) provides for the granting to employees of nonstatutory stock options for up to 1,000,000 shares of common stock. The exercise price of stock options granted under the 2001 Employee Plan may not be less than 100% of the fair market value of the shares of common stock subject to the option at the date of grant. The term of the options may not exceed 10 years and generally vest over four years. As of December 31, 2006, there were 78,000 shares available for grant under the 2001 Employee Plan.

8

 
 
2003 Stock Plan
 
The 2003 Stock Plan (“2003 Stock Plan”) provides for the granting to newly hired employees of nonstatutory stock options for up to 1,000,000 shares of common stock. The exercise price of stock options granted under the 2003 Stock Plan may not be less than 100% of the fair market value of the shares of common stock subject to the option at the date of grant. The term of the options may not exceed 10 years and generally vest over four years. As of December 31, 2006, there were 100,000 shares available for grant under the 2003 Employee Plan.
 
Sage Stock Option Plan
 
The Sage Stock Option Plan (“Sage Plan”) provided for the granting of ISOs to employees of Sage, a wholly owned subsidiary of Genesis and NSOs to Sage employees, directors, and consultants. As a result of the purchase of Sage in 2002, each outstanding option or right to purchase shares of Sage common stock is exercisable for Genesis shares of common stock, adjusted to reflect the exchange ratio of Genesis shares of common stock to Sage common stock in the purchase and sale agreement. No additional options will be granted under the Sage Plan. Upon exercise, expiration or cancellation of all of the options granted under the Sage Plan, this plan will be terminated.
 
Employee Stock Purchase Plan
 
Genesis has established an employee stock purchase plan under which employees may authorize payroll deductions of up to 15% of their compensation (as defined in the plan) to purchase shares of common stock at a price equal to 85% of the lower of the fair market values as of the beginning or the end of each six month purchase period within an offering period. The plan provides for the purchase of 500,000 shares of common stock plus an annual increase to restore the number of shares available for purchase under the plan to 500,000. As of December 31, 2006, there were 500,000 shares available for issuance under this plan.
 
Effective July 1, 2006, awards granted pursuant to the plan may be exercised at the end of each six month purchase period within a twelve month offering period. The offering period of awards granted prior to July 1, 2006 was approximately twenty-four months.
 
Summary of Stock Options
 
Details of stock option transactions are as follows:
 
 
 
Number
of
Options
(in thousands)
 
Weighted
Average
Exercise
Price
Per Share
 
Weighted
Average
Remaining
Life
(Years)
 
   
 
         
Outstanding, March 31, 2006
   
7,127
 
$
16.43
   
6.74
 
Granted
   
598
   
12.21
       
Exercised
   
(186
)
 
9.19
       
Forfeited
   
(71
)
 
16.56
       
Expired
   
(190
)
 
24.39
       
 
             
Outstanding, June 30, 2006
   
7,278
 
$
16.06
   
6.62
 
Granted
   
26
   
12.23
       
Exercised
   
(124
)
 
8.40
       
Forfeited
   
(276
)
 
15.79
       
Expired
   
(173
)
 
19.71
       
 
             
Outstanding, September 30, 2006
   
6,731
 
$
16.10
   
6.38
 
Granted
   
543
   
10.41
       
Exercised
   
(141
)
 
7.45
       
Forfeited
   
(166
)
 
15.31
       
Expired
   
(140
)
 
19.17
       
 
             
Outstanding, December 31, 2006
   
6,827
 
$
15.78
   
6.12
 
                     
Exercisable, December 31, 2006
   
4,459
 
$
16.64
   
5.88
 
               

9

 
 
During the three and nine months ended December 31, 2006, 272,549 and 1,145,443 stock options vested.
 
At December 31, 2006, compensation expense of $17,116,715 related to non-vested stock options has not been recognized. This cost is expected to be recognized over a weighted average period of 1.13 years. The total intrinsic value of options outstanding and options exercisable at December 31, 2006 was $1,860,498 and $1,850,163, respectively. The total intrinsic value of options exercised during the three and nine months ended December 31, 2006 was $440,522 and $1,666,651, respectively. The total intrinsic value of options exercised during the three and nine months ended December 31, 2005 was $1,108,110 and $17,910,276, respectively.
 
For the nine months ended December 31, 2006, cash in the amount of $5,560,000 was received as the result of the exercise of options granted under share-based payment arrangements which includes $3,060,000 for stock options exercised and $2,500,000 for the sale of shares in connection with the Employee Stock Purchase Plan.
 
Summary of Restricted Stock Units
 
Details of restricted stock unit transactions are as follows:
 
 
 
Number of Units
(in thousands) 
 
Weighted
Average
Grant-Date
Fair Value
 
   
 
     
Nonvested at March 31, 2006
   
266
 
$
19.93
 
Granted
   
203
   
12.89
 
Vested
   
(37
)
 
13.11
 
Forfeited
   
(9
)
 
18.98
 
Nonvested at June 30, 2006
   
423
 
$
16.62
 
Granted
   
129
   
12.37
 
Vested
   
(12
)
 
13.53
 
Forfeited
   
(20
)
 
15.21
 
Nonvested at September 30, 2006
   
520
 
$
15.53
 
Granted
   
233
   
10.27
 
Vested
   
(21
)
 
10.16
 
Forfeited
   
(17
)
 
14.64
 
Nonvested at December 31, 2006
   
715
 
$
13.71
 
 
At December 31, 2006, compensation expense of $5,977,675 related to non-vested restricted stock units has not been recognized. This cost is expected to be recognized over a weighted average period of 1.58 years. The total fair value of restricted stock units vested during the three and nine months ended December 31, 2006 was $221,660 and $870,910, respectively. No restricted stock units were granted or vested during the quarter and nine months ended December 31, 2005.
 
The Company's policy is to satisfy stock option exercises and RSUs by issuing new shares of common stock. No cash was used by the Company to settle equity instruments granted under stock-based compensation arrangements.

10

 
 
3. Earnings per share
 
Basic earnings (loss) per share are computed by dividing the net income (loss) in a period by the weighted average number of shares of common stock outstanding during that period. Diluted earnings (loss) per share is calculated in order to give effect to all potential dilutive shares of common stock issueable during the period on the exercise of outstanding options. The weighted average number of diluted shares outstanding is calculated by assuming that any proceeds from the issuance of potential shares of common stock, such as stock options, are used to repurchase shares of common stock at the average market share price in the period. Per share information calculated on this basis is as follows (in thousands, except for share amounts):

   
Three Months Ended
December 31
 
Nine Months Ended
December 31
 
   
2006
 
2005
 
2006
 
2005
 
Numerator for basic and diluted earnings (loss) per share:
                         
Net income (loss)
 
$
(130,437
)
$
7,365
 
$
(128,889
)
$
18,707
 
Denominator for basic earnings (loss) per share:
                         
Weighted average shares of common stock
   
36,585
   
35,413
   
36,342
   
34,632
 
                           
Basic earnings (loss) per share:
 
$
(3.57
)
$
0.21
 
$
(3.55
)
$
0.54
 
                           
Denominator for diluted earnings (loss) per share:
                         
Weighted average shares of common stock
   
36,585
   
35,413
   
36,342
   
34,632
 
Stock options (1)
   
-
   
1,882
   
-
   
2,086
 
                           
Shares used in computing diluted earnings (loss) per share
   
36,585
   
37,295
   
36,342
   
36,718
 
Diluted earnings (loss) per share:
 
$
(3.57
)
$
0.20
 
$
(3.55
)
$
0.51
 
Anti-dilutive potential shares of common stock excluded from above calculation
   
6,687
   
5,528
   
6,962
   
5,851
 

(1) For the three months and nine months ended December 31, 2006, excludes the effect of all stock options as they are anti-dilutive due to the loss reported in the period.

4. Segmented information
 
Market information
 
Genesis operates and monitors its results in one operating segment. Genesis designs, develops and markets integrated circuits that manipulate and process digital video and graphic images. The target market is the advanced display market including LCD monitors and digital televisions.
 
Geographic information
 
Geographic revenue information is based on the shipment destination. Long-lived assets include property and equipment, as well as intangible assets. Property and equipment information is based on the physical location of the asset while the intangible assets are based on the location of the owning entity.
 
Revenues from unaffiliated customers by geographic region were as follows (in thousands):

   
Three Months Ended 
December 31
 
Nine Months Ended
December 31
 
   
2006
 
2005
 
2006
 
2005
 
United States
 
$
124
 
$
393
 
$
965
 
$
3,103
 
China
   
20,126
   
31,964
   
71,908
   
91,183
 
Europe
   
6,210
   
10,104
   
21,001
   
23,232
 
Japan
   
6,591
   
7,537
   
18,423
   
22,016
 
South Korea
   
8,509
   
13,722
   
40,069
   
39,273
 
Taiwan
   
5,904
   
8,059
   
17,747
   
21,159
 
Rest of world
   
3,653
   
2,186
   
5,912
   
8,678
 
Total Revenue
 
$
51,117
 
$
73,965
 
$
176,025
 
$
208,644
 


11

 
 
Net long-lived assets by country were as follows (in thousands):
 
 
 
December 31,
2006 
 
March 31,
2006 
 
United States, including goodwill
 
$
93,139
 
$
197,561
 
Rest of world
   
11,225
   
9,934
 
 
 
$
104,364
 
$
207,495
 
 
Customer concentration information
 
The following table shows the percentage of our revenues in each period that was derived from customers who individually accounted for more than 10% of revenues in that period:
 
   
Three Months Ended
December 31
 
Nine Months Ended
December 31
 
   
2006
 
2005
 
2006
 
2005
 
Customer A
   
-
   
15%
 
 
15%
 
 
15%
 
Customer B
   
10%
 
 
10%
 
 
10%
 
 
10%
 
Customer C
   
-
   
-
   
11%
 
 
10%
 
 
The following table shows customers accounting for more than 10% of accounts receivable trade at December 31, 2006 and March 31, 2006:
 
 
 
December 31,
2006 
 
March 31,
2006 
 
Customer 1
   
24
%
 
22
%
Customer 2
   
11
%
 
12
%
Customer 3
   
-
   
12
%
Customer 4
   
-
   
11
%
 
Supplier arrangements
 
Genesis subcontracts most of its semiconductor manufacturing from several suppliers and, for the vast majority of products, no single production process for any single product is performed by more than one supplier. Should our wafer supplier or any of Genesis’s packaging or testing subcontractors cease to be available, management believes that this would have a material adverse effect on Genesis’s business, financial condition and results of operations. Genesis has no guarantee of minimum capacity from its suppliers, long term pricing agreements, and is not liable for any significant minimum purchase commitments.
 
5. Inventories
 
Inventories consist of the following (in thousands):
 
 
 
December 31,
2006 
 
March 31,
2006 
 
Finished goods
 
$
12,695
 
$
10,717
 
Work-in-process
   
9,423
   
10,123
 
 
   
22,118
   
20,840
 
Less: Inventory reserve
   
(4,150
)
 
(3,665
)
 
 
$
17,968
 
$
17,175
 
 
The following table presents a roll forward of the inventory obsolescence reserve for the indicated periods (in thousands):
 
   
 Three Months Ended
December 31
 
Nine Months Ended
December 31
 
   
2006
 
2005
 
2006
 
2005
 
Balance at beginning of period
 
$
3,126
 
$
2,331
 
$
3,665
 
$
2,954
 
Increase to provision
   
1,333
   
653
   
2,074
   
316
 
Write offs
   
(309
)
 
-
   
(1,589
)
 
(286
)
Balance at end of period
 
$
4,150
   
2,984
 
$
4,150
 
$
2,984
 
 

12

 
 
6. Product warranty
 
Genesis accrues the estimated future cost of replacing faulty products under the provisions of its warranty agreements as an increase to cost of revenues. Product warranties typically cover a one-year period from the date of delivery to the customer. Management estimates the accrual based on known product failures (if any), historical experience, and other currently available evidence and records the accrual within accrued liabilities. The following table presents a roll forward of the product warranty accrual for the indicated periods (in thousands):
 
   
Three Months Ended 
 
Nine Months Ended 
 
   
December 31 
 
December 31 
 
   
2006 
 
2005 
 
2006 
 
2005 
 
Balance at beginning of period
 
$
115
 
$
173
 
$
164
 
$
230
 
Increase to provision
   
10
   
2
   
270
   
5
 
Write offs
   
(6
)
 
(2
)
 
(315
)
 
(62
)
Balance at end of period
 
$
119
 
$
173
 
$
119
 
$
173
 

7. Intangible assets
 
Intangible assets consist of the following (in thousands):
 
 
 
December 31, 2006 
 
 
 
Cost 
 
Accumulated
Amortization 
 
Impairment 
 
Net
 
Acquired technology
 
$
48,475
 
$
44,017
 
$
3,425
 
$
1,033
 
Patents
   
4,876
   
1,255
   
   
3,621
 
Other
   
500
   
500
   
   
 
Total
 
$
53,851
 
$
45,772
 
$
3,425
 
$
4,654
 
 
 
 
March 31, 2006 
 
 
 
Cost 
 
Accumulated
Amortization 
 
Impairment 
 
Net
 
Acquired technology
 
$
47,953
 
$
42,029
 
$
 
$
5,924
 
Patents
   
4,118
   
987
   
   
3,131
 
Other
   
500
   
500
   
   
 
Total
 
$
52,571
 
$
43,516
 
$
 
$
9,055
 
 
Due to a decline in projected revenue, for products which incorporate technology acquired from VM Labs in fiscal 2002, the Company determined a triggering event occurred in the quarter ending December 31, 2006. The Company engaged an independent valuation professional to assist with its measurement of fair value as part of the intangible asset impairment test. The recoverability of this asset was assessed by comparing its carrying amount with its estimated fair value using a discounted cash flow approach. An impairment was identified for which the Company recorded a non-cash impairment charge of $3,425,000 prior to performing the goodwill impairment analysis.
 
Estimated future intangible assets’ amortization expense, based on current balances as of December 31, 2006, is as follows (in thousands):

       
For the year ended March 31:
     
2007
 
$
187
 
2008
   
748
 
2009
   
752
 
2010
   
516
 
2011
   
360
 
Thereafter
   
2,091
 
Total
 
$
4,654
 
 
 
13

 
8.  Goodwill
 
 
 
 
 
Goodwill, opening balance
 
$
181,981
 
Impairment charge
   
(97,576
)
Goodwill, closing balance
 
$
84,405
 
 
The Company is required to evaluate goodwill annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Due to a sustained reduction in the Company’s market capitalization plus the decline in current and projected revenue from certain customers, the Company determined a triggering event occurred in the quarter ending December 31, 2006 requiring management to assess the recoverability of goodwill. Impairment is tested at the reporting unit level by comparing the reporting unit’s carrying amount to its fair value. Where the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized for the amount by which the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill.
 
Management has determined that the Company has one reporting unit for purposes of goodwill impairment review under SFAS 142. Upon performing the impairment test, it was found that the carrying value of goodwill exceeded its implied fair value of $84,405,000 and therefore an impairment charge of $97,576,000 was recorded in the current quarter. The Company engaged an independent valuation professional to assist with its measurement of fair value as part of the goodwill impairment test. The fair value of the reporting unit was estimated using a combination of the market approach and a discounted cash flows approach.
 
9. Other long-term assets
 
Other long-term assets consist of the following (in thousands):
 
 
 
December 31, 2006 
 
March 31, 2006 
 
 
 
Cost 
 
Accumulated
Amortization 
 
Net 
 
Cost 
 
Accumulated
Amortization 
 
Net 
 
Investments, at cost
 
$
10,225
 
$
 
$
10,225
 
$
11,177
 
$
 
$
11,177
 
Production mask sets
   
10,270
   
4,642
   
5,628
   
7,857
   
2,775
   
5,082
 
Total
 
$
20,495
 
$
4,642
 
$
15,853
 
$
19,034
 
$
2,775
 
$
16,259
 
 
10. Income Taxes
 
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of its deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible in the appropriate jurisdiction. Management considers projected future taxable income, uncertainties related to the industry in which Genesis operates and tax planning strategies in making this assessment.  Historically, the Company has recorded the majority of its valuation allowance against its tax attributes in the United States.   FASB Statement No. 109, Accounting for Income Taxes, states that forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence, such as losses in the jurisdictions to which the deferred tax asset relate.  As a result of the review undertaken in the third quarter of fiscal 2007, the Company concluded that it was appropriate to establish a full valuation allowance in the financial statements against the tax attributes in Canada and recorded an additional valuation allowance of $16,778,000.  In addition, the Company expects to provide a full valuation allowance on future tax benefits until it can demonstrate a sustained level of profitability that establishes its ability to utilize the assets in the jurisdictions to which the assets relate. Furthermore, in the near term the company expects approximately $1 million of income tax expense per quarter, while the Company expects to incur operating losses.
 
11. Related party transactions
 
In March 2006, Genesis made an equity investment in Mobilygen Corp, and Elias Antoun, our president and CEO, joined Mobilygen’s Board of Directors.
 
In April 2006, we entered into a cross-licensing agreement with Mobilygen Corp., a privately held company that is developing H.264 and other video codec solutions for mobile devices. The agreement will give both companies access to certain technologies for select markets and enables them to jointly define future products to complement existing product portfolios.

14

 
 
The investment in Mobilygen is recorded within other long term assets. No financial transactions were undertaken with Mobilygen during the three and nine months ended December 31, 2006.
 
12. Contingent liabilities
 
Silicon Image Litigation
 
In April 2001, Silicon Image, Inc. (“Silicon Image”) filed a patent infringement lawsuit against Genesis in the United States District Court for the Eastern District of Virginia (“District Court”) and simultaneously filed a complaint before the United States International Trade Commission (“ITC”). The complaint and suit alleged that certain Genesis products that contain digital receivers infringe various Silicon Image patent claims. Silicon Image was seeking an injunction to halt the sale, manufacture and use of Genesis’s DVI receiver products and unspecified monetary damages. In December 2001, Silicon Image formally moved to withdraw its complaint before the ITC, and those proceedings have terminated.
 
In July 2003, the District Court issued a memorandum opinion, followed by a final judgment in August 2003 and an amended final judgment in December 2003. In its opinion, the District Court ruled that Genesis and Silicon Image have settled their disputes based on a Memorandum of Understanding (“MOU”) signed on December 18, 2002. The District Court’s opinion states that the MOU is a binding settlement agreement and that Genesis will pay Silicon Image a monetary settlement, license fee and running royalties on all DVI and HDMI products. We recorded a provision for costs associated with this patent litigation in the year ended March 31, 2003, a portion of which was paid in escrow to the court in August 2003. An additional undisclosed amount was paid to the court as a bond in March 2004. The payments to the court have been accounted for as reductions of the related liability.
 
In January 2004, Genesis filed a notice of appeal to the United States Court of Appeals for the Federal Circuit. In April 2006, the Court of Appeals affirmed the District Court’s decision.
 
On December 21, 2006, Genesis entered into a Settlement and License Agreement with Silicon Image (the “Agreement”), granting Genesis a license to certain Silicon Image patents and settling the dispute over the interpretation of the MOU. The Agreement supersedes the MOU.
 
Pursuant to the Agreement, Genesis receives a worldwide, nonexclusive license to all Silicon Image patents with a priority date on or before September 1, 2006. In exchange for the license, Genesis agreed to pay Silicon Image a lump sum payment of $4.5 million, plus accrued and running royalties on all Genesis receiver and transmitter products compliant with the DVI 1.0 or HDMI 1.0 standards, and any minor updates to the HDMI 1.0 standard such as HDMI 1.3. The amounts of the royalties are confidential. The term of the Agreement is through September 17, 2014, unless earlier terminated pursuant to the Agreement. The $4.5 million amount was recorded in selling, general and administration in the quarter ending December 31, 2006 and was paid in January 2007. The accrued royalties related to shipments for the quarter ending December 31, 2006 were recorded in cost of sales.
 
By signing the Agreement, the parties also agreed to a mutual release of claims against each other for causes of action and liability arising prior to the effective date of the Agreement relating to the MOU, the patent litigation settled by the MOU and subsequent litigation over the interpretation of the MOU, all claims and counterclaims in such litigations, and claims of infringement of any Silicon Image licensed patent by the manufacture, use, offer for sale, sale or importation of a royalty-bearing product. However, the foregoing release does not affect Genesis’s right to challenge claims, counterclaims or defenses with respect to the patents Silicon Image asserted in the prior litigation, including noninfringement, invalidity or unenforceability, provided that any such challenge by Genesis shall only be in response to an assertion or reasonable apprehension of assertion of such patents against Genesis or the use, manufacture, importation, offering for sale or sale of Genesis products, or products incorporating a Genesis product, by Genesis’s suppliers, manufacturers, licensees, distributors, resellers or customers.
 
The Agreement also provides for a mutual covenant not to sue the other party for a period of three years.
 
Silicon Image’s license grant and covenant not to sue, as set forth in the Agreement, are assignable on a change of control of Genesis to an acquiror of Genesis, with respect to Genesis products that have been commercially produced and sold prior to the change of control date. Silicon Image’s covenant not to sue shall continue only for the remainder of the term of the covenant and only with respect to patents owned by Silicon Image existing at the time of the change of control.

15

 
 
Genesis’s covenant not to sue is assignable on a change of control of Silicon Image to an acquiror of Silicon Image, with respect to Silicon Image products that have been commercially produced and sold prior to the change of control date, and shall continue only for the remainder of the term of the covenant and only with respect to patents owned by Genesis existing at the time of the change of control.
 
The Agreement also contains audit rights, governing law and jurisdiction, and other customary terms.
 
MStar Litigation
 
Genesis filed a patent infringement complaint against MStar Semiconductor, Inc. (“MStar”) in the ITC in 2003. In August 2004, the ITC determined that MStar and the other respondents infringe Genesis’s patent, and issued an exclusion order preventing the importation of MStar’s and the other respondents’ infringing display controllers into the United States, as well as LCD monitors and boards containing these products. However, U.S. Customs declined to enforce the ITC’s exclusion order against MStar’s Tsunami (or TSU) products. In December 2004, MStar filed an appeal of the exclusion order and related ITC rulings to the Federal Circuit Court of Appeals. In May 2006, the Court of Appeals upheld the ITC’s decision in favor of Genesis. Also, in April 2006, Genesis filed a motion to enforce the exclusion order against MStar’s Tsunami products in the ITC. The ITC instituted an investigation in June 2006.
 
In October 2006, Genesis and MStar entered into an agreement to settle the litigation and to provide a license to MStar to certain Genesis patents in exchange for undisclosed running royalties. Royalties received in the quarter ending December 31, 2006 have been recorded as royalty revenue. This license allows MStar to ship the infringing products into the United States. Following the settlement, Genesis and MStar jointly filed a motion to terminate the ITC proceedings which was granted on December 6, 2006.
 
Securities Class Action Litigation
 
In November 2002, a punitive securities class action captioned Kuehbeck v. Genesis Microchip et al., Civil Action No. 02-CV-05344, was filed against Genesis, former Chief Executive Officer Amnon Fisher, and former Interim Chief Executive Officer Eric Erdman, and amended in July 2003 to include Executive Vice President Anders Frisk (collectively the “Individual Defendants”) in the United States District Court for the Northern District of California. The complaint alleges violations of Section 10(b) of the Securities and Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder against Genesis and the Individual Defendants, and violations of Section 20(a) of the Exchange Act against the Individual Defendants. The complaint sought unspecified damages on behalf of a purported class of purchasers of Genesis’s common stock between April 29, 2002 and June 14, 2002. In July 2005, the court granted Genesis’s motion to dismiss the case, with prejudice. The plaintiffs filed an appeal to the Ninth Circuit Court of Appeals. The parties signed an agreement to settle the case in March 2006. In August 2006, the court issued an order preliminarily approving the settlement. On December 8, 2006, the court issued a final judgment approving the settlement and dismissing the case with prejudice. There were no accounting implications in the quarter ending December 31, 2006.
 
13. Recent Accounting Pronouncement
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109” (“FIN 48”). FIN 48 requires that companies recognize the tax benefits of uncertain tax positions only where the position is “more likely than not” to be sustained, assuming examination by tax authorities. The amount recognized would be the amount that represents the largest amount of tax benefit that is greater than 50% likely of being ultimately realized. A liability would be recognized for the taxes attributable to any benefit claimed, or expected to be claimed, in a tax return in excess of the amount of the uncertainty that is eligible to be recognized as a benefit in the financial statements, along with any interest and penalty (if applicable) on the excess. Discussion will also be required for those uncertain tax positions where it is reasonably possible that the estimate of the tax benefit will change significantly in the next 12 months. FIN 48 is effective for fiscal years beginning after December 15, 2006. The effect, if any, of adopting FIN 48 on the Company’s consolidated financial statements is currently being evaluated by management.

Statement of Financial Accounting Standards No. 157, “Fair Value Measurement” (“SFAS 157”) was issued in September 2006. SFAS 157 provides guidance for using fair value to measure assets and liabilities. SFAS 157 also expands disclosures about the extent to which companies measure assets and liabilities at fair value, the information used to measure fair value, and the effect of fair value measurement on earnings. SFAS 157 applies under other accounting pronouncements that require or permit fair value measurements. SFAS 157 does not expand the use of fair value measurements in any new circumstances. Under SFAS 157, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts. SFAS 157 is effective for the Company for fair value measurements and disclosures made by the Company in its fiscal year beginning on April 1, 2008. The Company is currently reviewing the impact of this statement.

16

 
 
In September 2006, the U.S. Securities and Exchange Commission issued Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (“SAB 108”). SAB 108 provides interpretive guidance on how the effects of the carryover or reversal of prior year misstatements should be considered in quantifying a current year misstatement. SAB 108 requires registrants to quantify misstatements using both the balance sheet and income statement approaches and to evaluate whether either approach results in quantifying an error that is material in light of relevant quantitative and qualitative factors. SAB 108 does not change the staff’s previous guidance in SAB 99 on evaluating the materiality of misstatements. When the effect of initial adoption is determined to be material, SAB 108 allows registrants to record that effect as a cumulative-effect adjustment to beginning-of-year retained earnings under U.S. GAAP. SAB 108 is effective for the Company’s annual financial statements for the current fiscal year ending March 31, 2007. The Company is currently reviewing the impact of this pronouncement.

17

 
 
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding anticipated revenues, gross margins, operating expenses, amortization of intangibles and stock-based compensation, liquidity and cash flow, business strategy, demand for our products, average selling prices, regional market growth, amount of sales to distributors and future competition. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions identify such forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors which could cause actual results to differ materially include those set forth in the following discussion, and, in particular, the risks discussed below under the subheading “Risk Factors” and in other documents we file with the Securities and Exchange Commission. Unless required by law, we undertake no obligation to update publicly any forward-looking statements.
 
We begin Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) with a general discussion of our target markets, the nature of our products, and some of the business issues we are facing as a company. Next, we address the Critical Accounting Policies and Estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results. We then discuss our Results of Operations for the three and nine month periods ended December 31, 2006 and December 31, 2005 as viewed through the eyes of our management. Lastly, we provide an analysis of changes in our balance sheet and cash flows, and discuss our financial commitments. This MD&A should be read in conjunction with the other sections of this Quarterly Report on Form 10-Q.
 
OVERVIEW
 
We develop and market image-processing and image enhancing solutions. We design, develop and market integrated circuits that receive and process digital video and graphic images. We also supply reference boards and designs that incorporate our software and proprietary integrated circuits, or chips. We have recently introduced a panel timing controller product. Our products are primarily used in large-area liquid crystal displays (“LCDs”). These displays may be used in desktop monitor applications or other types of display devices, including LCD TVs, Plasma TVs, Rear Projection TVs, Digital CRT TVs, DVD players and AVRs (Audio/Video Receivers).
 
We generate the majority of our revenue by selling our image-processing solutions to the manufacturers of LCD monitors, flat panel displays and television sets. We outsource the manufacturing of our products to large semiconductor manufacturers, thereby eliminating the need for capital-intensive plant and equipment. Our most significant cash operating expense is labor, with our workforce employed in research and development of new products and technologies and in marketing, sales, customer support, and distribution of our products.
 
Our primary target end-markets are LCD computer monitors and flat panel televisions. We also design products that serve both applications, so-called multi-function monitors, and it is difficult to distinguish between a monitor with television capability and a television with a PC input. Both of these display devices could use the same Genesis chip. Similarly, we supply certain customers with chips originally designed for an LCD computer monitor that the customer may use in flat panel televisions. We assist customers in developing their designs. Typically, a TV design will take substantially more time and support from our software application and field application engineers than a monitor design, increasing our costs during a customer’s pre-production period.
 
The growth in our target markets is limited by the industry’s capacity to supply LCD panels or other digital displays. Furthermore, the availability of LCD panels from time to time has been constrained, causing unexpected increases in the cost of LCD panels to our customers, thus resulting in customers rapidly changing their demand expectations for our products. Our products usually represent less than two percent of the average retail cost of a standard flat panel TV today, while the cost of the LCD panel within a LCD computer monitor or flat panel TV represents the majority of the cost of the finished product. The increase in production volumes of larger size LCD panels in new fabrication facilities coming on line over the next few years is expected to result in lower-cost panels and hence lower average selling prices of the end product. We believe retail prices for televisions will continue to decline and we expect this trend to lead to an increase in demand for display controllers.
 
18

 
The LCD computer monitor and flat panel TV industries are very competitive and growth industries like ours tend to attract new entrants. The average selling prices of monitor display controllers, in spite of increased functionality have declined by more than 40% over the past two fiscal years. Our strategy is to lead the market by integrating new features and functions and by providing the highest image quality at a cost-effective price. Our goal is to deliver the desired feature-rich image quality through relationships with customers, patented technologies, effective chip design, software capabilities, and customer support. We also strive to generate profitability by reducing product cost through efficient chip design and driving costs down throughout our supply chain.
 
Sales to distributors comprised approximately 26% of revenue for the three months and 22% for the nine months ended December 31, 2006. We are also using distributor relationships to enable us to increase our market penetration of smaller customers with minimal incremental direct customer support.
 
Average selling prices and product margins of our products are typically highest during the initial periods following product introduction and decline over time and as volume increases.
 
Part of our overall strategy is to develop intellectual property that is used in our integrated circuits. We have and will continue to defend our intellectual property rights against those companies that may use our technology without the proper authorization. At times we may enter into agreements that allow customers or other companies to license our patented technology.
 
Revenue Recognition
 
Genesis recognizes revenue from semiconductor product sales to customers when a contract is established, the price is determined, shipment is made and collectibility is reasonably assured. Product sales to distributors may be subject to agreements having a right of return on termination of the distributor relationship. Revenue, and related cost of revenues from sales to distributors, is deferred until the distributors resell the product, verified by point-of-sale reports. At the time of shipment to distributors, we record a trade receivable for the selling price, relieve inventory of the value of the product shipped and record the gross margin as deferred revenue, a component of accrued liabilities on our consolidated balance sheet. In certain circumstances, where orders are placed with non-cancelable/non-return terms, we recognize revenue upon shipment. Reserves for sales returns and allowances are recorded at the time of recognizing revenue. To date, we have not experienced significant product returns.
 
Manufacturing and Supply
 
We generally need to place purchase orders for products before we receive purchase orders from our customers. This is because production lead times for silicon wafers and substrates, from which our products are manufactured, can be as long as three to four months, while many of our customers place orders only one month or less in advance of their requested delivery date. We have agreements with suppliers in Asia such that we are dependent on the suppliers’ manufacturing yields. We continue to review and, where feasible, establish alternative sources of supply to reduce our reliance on individual key suppliers and reduce lead times, though dual sourcing for specific products sometimes is more costly due to initial set-up costs and lower initial yields as each new manufacturing supplier ramps up production. While we have frequent communication with significant customers to review their requirements, we are restricted in our ability to react to fluctuations in demand for our products, which exposes us to the risk of having either too much or not enough of a particular product. We regularly evaluate the carrying value of inventory held. For the quarter ended December 31, 2006, we recorded net reserves totaling $1,333,000 for inventory which we did not foresee sufficient demand to support the carrying value or where the market price was less than our actual cost.
 
Global Operations
 
We operate through subsidiaries and offices in several countries throughout the world. Our head office is located in Alviso (Silicon Valley), California. Our research and development resources are located in the United States, Canada and India. The majority of our customers are located in Asia, supported by our sales offices in China, Germany, Japan, Singapore, South Korea, and Taiwan. Our third party suppliers are located primarily in Taiwan. Although all of our revenues and virtually all of our costs of revenues are denominated in U.S. dollars, portions of our operating expenses are denominated in foreign currencies. Accordingly, our operating results are affected by changes in the exchange rate between the U.S. dollar and those currencies. Any future strengthening of those currencies against the U.S. dollar could negatively impact our operating results by increasing our operating expenses as measured in U.S. dollars.
 
19

 
We do not currently engage in any hedging or other transactions intended to manage the risks relating to foreign currency exchange rate fluctuations, other than natural hedges that occur as a result of holding both assets and liabilities denominated in foreign currencies. Our operating expenses are also affected by changes in the rate of inflation in the various countries in which we operate.
 
Mergers and Acquisitions
 
Technology companies often use mergers, acquisitions and strategic investments to accelerate development of products, to realize potential synergies or to enter new markets. We have made significant acquisitions in the past, for example Sage Inc. in February 2002, resulting in the recording of significant intangible assets and goodwill on our balance sheet.

In March 2006, Genesis made an equity investment in Mobilygen, and Elias Antoun, our president and CEO, joined Mobilygen’s Board of Directors. In April 2006, we entered into a cross-licensing agreement with Mobilygen Corp., a privately held company that is developing H.264 and other video codec solutions for mobile devices. The agreement will give both companies access to certain technologies for select markets and enables them to jointly define future products to complement existing product portfolios.
 
For details on other mergers, acquisitions and strategic investments, please refer to previously filed Annual and Quarterly Reports.
 
Critical Accounting Policies and Estimates
 
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. As described below, significant estimates are used in determining the allowance for doubtful accounts, inventory obsolescence provision, deferred tax asset valuation, potential settlements and costs associated with patent litigation, royalty obligations to third parties and the useful lives of intangible assets. We evaluate our estimates on an on-going basis, including those related to product returns, bad debts, inventories, investments, intangible assets, income taxes, warranty and royalty obligations, litigation and other contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
 
We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements:
 
·
We record estimated reductions to revenue for customer returns based on historical experience. A customer has a right to return products only if the product is faulty or upon termination of a distributor agreement, although in certain circumstances we agree to accept returns if replacement orders are placed for other products or to maintain our business relationship. If actual customer returns increase, we may be required to recognize additional reductions to revenue.
 
·
We record the estimated future cost of replacing faulty product as an increase to cost of revenues. To date we have not experienced significant returns related to quality. If returns increase as a result of changes in product quality, we may be required to recognize additional warranty expense.
 
·
We maintain allowances for estimated losses resulting from the inability of our customers to make required payments and other disputes. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We have not suffered any significant loss in this area.
 
·
We provide for inventory obsolescence reserves against our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those we project, additional inventory valuation reserves may be required.
 
·
We account for stock-based compensation in accordance with Statement of Financial Accounting Standards (SFAS) No. 123R, Share-Based Payment. Under the provisions of SFAS No. 123R, stock based compensation is estimated at the grant date based on the award’s fair-value as calculated by the Black-Scholes option-pricing model and is recognized as expense ratably over the requisite service period. The Black-Scholes model requires various highly judgmental assumptions including volatility, forfeiture rates and expected option life. If any of the assumptions change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period.
 
 
20

 
·
We provide for costs associated with settling litigation when we believe that we have a reasonable basis for estimating those costs. If actual costs associated with settling litigation differ from our estimates, we may be required to recognize additional costs.
 
·
Goodwill, which represents the excess of cost over the fair value of net assets acquired in business combinations, is tested annually for impairment, and is tested for impairment more frequently if events and circumstances indicate that the goodwill might be impaired. The impairment tests are performed in accordance with FASB Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets”. Accordingly, an impairment loss is recognized to the extent that the carrying amount of goodwill exceeds its implied fair value. This determination is made at the reporting unit level. We have assigned all goodwill to a single, enterprise-level reporting unit. The impairment test consists of two steps. First, we determine the fair value of the reporting unit. The fair value is then compared to its carrying amount. Second, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill would be determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation in accordance with FASB Statement of Financial Accounting Standards No. 141, “Business Combinations”. The residual fair value after this allocation is the implied fair value of the reporting unit goodwill. We perform our annual impairment test on January 1st of each year.
 
We did not record any goodwill impairment charges in fiscal 2006, 2005, or 2004. As a result of an impairment review that was performed in December 2006, the Company recorded a goodwill impairment charge of $97.6 million in the quarter ended December 31, 2006. Goodwill balances may also be affected by changes in other estimates, for example, related to the ability to utilize acquired tax benefits, made at the time of acquisitions.
 
·
We record a valuation allowance to reduce our deferred tax assets to the amount that we believe is more likely than not to be realized. The Company has, and expects to continue to provide a full valuation allowance on future tax benefits until, it can demonstrate a sustained level of profitability that establishes its ability to utilize the assets in the jurisdictions that the assets relate.
 
·
From time to time, we incur costs related to potential merger and acquisition activities. When we assess that we will be the acquirer for accounting purposes in such transactions and we expect to complete the transaction, direct costs associated with the acquisition are deferred and form part of the final purchase price. In the event these assessments change, any such deferred costs would be expensed. Costs associated with other merger activities are expensed as incurred.
 
 
21

 
RESULTS OF OPERATIONS
 
THREE MONTHS ENDED DECEMBER 31, 2006
 
REVENUE AND GROSS PROFIT
 
The following table shows unaudited statement of operations data for the three months ended December 31, 2006 and December 31, 2005 (in thousands):
 
 
 
Three months ended
December 31 
 
 
 
2006 
 
2005 
 
Total revenue
 
$
51,117
 
$
73,965
 
Gross profit
   
20,856
   
34,203
 
Gross profit percentage
   
40.8
%
 
46.2
%
Revenue by geography:
         
United States
 
$
124
 
$
393
 
China
   
20,126
   
31,964
 
Europe
   
6,210
   
10,104
 
Japan
   
6,591
   
7,537
 
South Korea
   
8,509
   
13,722
 
Taiwan
   
5,904
   
8,059
 
Rest of world
   
3,653
   
2,186
 
 
         
Total revenue
 
$
51,117
 
$
73,965
 
 
Total Revenues
 
Revenues for the three months ended December 31, 2006 decreased by 31% to $51.1 million from $74.0 million for the three months ended December 31, 2005 due to lower unit shipments and average selling price declines. Unit shipments decreased by 18% to 14.0 million units for the quarter ended December 31, 2006 compared to 16.7 million units for the same period last year. In addition, the average selling prices (“ASPs”) decreased by 15% when compared to the same period last year. We expect overall ASP declines to continue for the foreseeable future.
 
Our products are designed for multiple applications. Therefore, we must estimate whether the chips we have sold are used in LCD monitors or flat-panel televisions. Estimated revenue from monitor controllers and licensing decreased to $22.8 million for the quarter ended December 31, 2006 from $29.6 million for the same period last year, due to lower unit shipments and ASP declines of 22%. Our estimate of quarterly unit shipments into digital televisions and other related video devices decreased by 29% compared to the same period last year, estimated revenue from this market decreased by 36% to $28.3 million. During the third quarter of fiscal 2007, we estimate that approximately 55% of total revenue was from TV and video products, compared with 60% for the same period last year. We expect a decline in revenue in the fourth quarter of our fiscal 2007, due to the seasonal nature of our TV business and a decline in  projected revenue from certain customers.
 
We continue to ship the majority of our product to customers located in Asia, and we expect most of our revenue to come from this region in the future, especially China.
 
Gross Profit
 
Gross profit for the three months ended December 31, 2006 was $20.9 million compared to $34.2 million for the three months ended December 31, 2005. Gross profit represented 40.8% of revenues for the three months ended December 31, 2006, compared with 46.2% for the same period last year. The decrease in the gross profit percentage is primarily due to a lower percentage of the higher margin TV business, increased pricing pressures on our products and an increase in inventory reserves during the three months ended December 31, 2006, partially offset by royalty revenue received during the current quarter. We expect a decline in gross profit percentage during the fourth quarter of fiscal 2007, due to a decline in higher margin TV business, the impact of the fixed component of cost of sales at lower levels of revenue and a reduction in royalty revenue. 
 
22


OPERATING EXPENSES
 
Research and Development
 
 
 
Three Months Ended 
 
 
 
December 31,
2006
 
December 31,
2005
 
 
 
$000 
 
% of
Revenue 
 
$000 
 
% of
Revenue 
 
Research and development
 
 
15,621
   
30.6
%
 
12,541
   
17.0
%
 
Research and development expenses include costs associated with research and development personnel, application engineers, development tools, hardware and software licenses, prototyping and the amortization of acquired intangibles.
 
Research and development expenses for the three months ended December 31, 2006 were $15.6 million, compared with $12.5 million in the three months ended December 31, 2005. This 25% increase is a reflection of the continued investment in the research and development of technologies addressing the television and video markets, especially the digital TV market and other related technologies, such as timing controllers and Display Port, a new digital interconnect standard. In addition, the mix of spending has changed, as we devote increasing resources to improving performance and integration of the more complex multimedia and video applications, especially digital TV technologies, while the focus within the monitor applications has moved more towards technologies supporting multi-function monitors. Genesis’s move towards lower geometry processes, including 0.13 micron and lower, for its highly integrated SOC digital TV chips has also increased research and development spending.
 
The increase in research and development expenses is also due to an increase in stock-based compensation charges, and increased headcount and an increase in the amortization of acquired intangibles. Research and development expenses for the quarters ended December 31, 2006 and December 31, 2005 include stock based compensation charges of $2.0 million and $0.1 million, respectively, and amortization of acquired intangibles of $1.0 million and $0.7 million, respectively.
 
Selling, General and Administrative
 
 
 
Three Months Ended 
 
 
 
December 31,
2006
 
December 31,
2005
 
 
 
$000 
 
% of
Revenue 
 
$000 
 
% of
Revenue 
 
Selling, general and administrative
   
19,786
   
38.7
%
 
12,195
   
16.5
%
 
Selling, general and administrative expenses consist of personnel and related overhead costs for selling, including field application engineers, product marketing, marketing communications, customer support, finance, human resources, legal costs (including settlement fees), IT, public company costs related, but not limited to, our compliance with the Sarbanes Oxley Act of 2002, general management functions and commissions paid to sales representatives.
 
Selling, general and administrative expenses for the three months ended December 31, 2006, were $19.8 million, compared with $12.2 million in the three months ended December 31, 2005. The increase in selling, general and administrative expenses is mostly due to an increase in stock-based compensation of $2.0 million and a legal settlement of $4.5 million that was recorded in the third quarter of fiscal 2007. Selling, general and administrative expenses for the quarters ended December 31, 2006 and December 31, 2005 include stock-based compensation charges of $2.3 million and $0.3 million, respectively.
 
Impairment of goodwill and intangibles

 
 
Three Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Impairment of goodwill and intangibles
   
101,001
   
 


23

 
We are required to evaluate goodwill annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Due to a sustained reduction in our market capitalization plus the decline in current and projected revenue from certain customers, we determined a triggering event occurred in the quarter ending December 31, 2006 requiring management to assess the recoverability of goodwill. Impairment is tested at the reporting unit level by comparing the reporting unit’s carrying amount to its fair value. Where the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized for the amount by which the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill.
 
We have determined that the Company has one reporting unit for purposes of goodwill impairment review under SFAS 142. Upon performing the impairment test, it was found that the carrying value of goodwill exceeded its implied fair value of $84.4 million and therefore an impairment charge of $97.6 million was recorded in the current quarter. We engaged an independent valuation professional to assist with our measurement of fair value as part of the goodwill and intangible asset impairment tests. The fair value of the reporting unit was estimated using a combination of the market approach and a discounted cash flows approach.
 
Due to a decline in projected revenue, for products which incorporate technology acquired from VM Labs in fiscal 2002, we determined a triggering event occurred in the quarter ending December 31, 2006. Management assessed the recoverability of this asset by comparing its carrying amount with its estimated fair value using a discounted cash flow approach. An impairment was identified for which we recorded a non-cash impairment charge of $3.4 million prior to performing the goodwill impairment analysis.

NON OPERATING INCOME AND EXPENSES
 
Interest and Other Income
 
 
 
Three Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Interest and other income
   
2,324
   
1,519
 
 
Interest income includes interest earned on cash, cash equivalents and short-term investments.
 
Interest income earned for the three months ended December 31, 2006 was $2.3 million compared with $1.5 million for the three months ended December 31, 2005. The increase is due to the combined effects of higher average cash, cash equivalents and short-term investments and higher average interest rates during the third quarter of fiscal 2007 compared to the same period last year.

Provision for Income Taxes

 
 
Three Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Income tax expense
   
17,209
   
3,621
 
 
We recorded a net income tax expense of $17.2 million for the three months ended December 31, 2006 compared to an expense of $3.6 million for the three months ended December 31, 2005.
 
Our accounting effective tax rate typically differs from the expected statutory rates due to several permanent differences including, but not limited to, research and experimental development tax credits, stock-based compensation expense for which no tax benefits can be recognized, foreign exchange fluctuations on the U.S. dollar working capital balances of foreign subsidiaries, and differences in tax rates in foreign jurisdictions. Any net tax benefit of these items is partially offset by changes in the valuation allowance against net operating loss carry forwards. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of our deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible in the appropriate jurisdiction. Management considers projected future taxable income, uncertainties related to the industry in which Genesis operates and tax planning strategies in making this assessment.  Historically, we have recorded the majority of our valuation allowance against the tax attributes in the United States.   FASB Statement No. 109, Accounting for Income Taxes, states that forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence, such as losses in the jurisdictions to which the deferred tax asset relate.  As a result of the review undertaken in the third quarter of fiscal 2007, we concluded that it was appropriate to establish a full valuation allowance in the financial statements against the tax attributes in Canada and recorded an additional valuation allowance of $16.8 million.  In addition, we expect to provide a full valuation allowance on future tax benefits until we can demonstrate a sustained level of profitability that establishes our ability to utilize the assets in the jurisdictions to which the assets relate. Furthermore, in the near term we expect approximately $1 million of income tax expense per quarter, while we expect to incur operating losses.
 
24


NINE MONTHS ENDED DECEMBER 31, 2006

REVENUE AND GROSS PROFIT

The following table shows unaudited statement of operations data for the nine months ended December 31, 2006 and December 31, 2005 (in thousands):

   
 Nine Months Ended
 
   
 December 31
 
   
2006
 
2005
 
Total revenue
 
$
176,025
 
$
208,644
 
Gross profit
   
74,299
   
91,289
 
Gross profit percentage
   
42.2
%
 
43.8
%
               
Revenue by geography:
             
United States
 
$
965
 
$
3,103
 
China
   
71,908
   
91,183
 
Europe
   
21,001
   
23,232
 
Japan
   
18,423
   
22,016
 
South Korea
   
40,069
   
39,273
 
Taiwan
   
17,747
   
21,159
 
Rest of world
   
5,912
   
8,678
 
Total revenue
 
$
176,025
 
$
208,644
 

Total Revenues

Revenues for the nine months ended December 31, 2006 decreased by 16% to $176.0 million from $208.6 million for the nine months ended December 31, 2005. Unit shipments remained relatively flat at 46.6 million units for the nine months ended December 31, 2006 compared to 46.7 million units for the same period last year. The revenue decrease is attributed to the declining ASPs of 15%.

Our products are designed for multiple applications. Therefore, we must estimate whether the chips we have sold are used in LCD monitors or flat-panel televisions. We estimate that units shipped into the LCD monitor market as well as shipments into the TV/video market remained flat on a year over year basis. On a product basis, ASPs declined 22% in the monitor market and 9% in the TV/video market. We estimate that unit shipments of flat-panel TV controller products increased by 3%.

We estimate that approximately 60% of total revenue was from consumer TV/video related products for the nine months ended December 31, 2006, compared with 56% for the nine months ended December 31, 2005. We expect a decline in revenue in the fourth quarter of fiscal 2007, due to the seasonal nature of our TV business and a decline in projected revenue from certain customers.

Gross Profit

Gross profit for the nine months ended December 31, 2006 decreased to $74.3 million from $91.3 million for the nine months ended December 31, 2005. Gross profit represented 42.2% of revenues for the nine months ended December 31, 2006, compared with 43.8% for the nine months ended December 31, 2005. The decrease in the gross margin percentage is mainly due to pricing pressures on our products, increased inventory provision recorded in the nine months ending December 31, 2006, partially offset by royalty revenue recorded in the nine months ended December 31, 2006. We expect a decline in gross profit percentage during the fourth quarter of fiscal 2007, due to a decline in higher margin TV business, the impact of the fixed component of cost of sales at lower levels of revenue and a reduction in royalty revenue.
 
25


OPERATING EXPENSES

Research and Development

 
 
Nine Months Ended 
 
 
 
December 31,
2006
 
December 31,
2005
 
 
 
$000 
 
% of
Revenue 
 
$000 
 
% of
Revenue 
 
Research and development
 
 
47,939
   
27.2
%
 
35,045
   
16.8
%

Research and development expenses for the nine months ended December 31, 2006 were $47.9 million, compared with $35.0 million in the nine months ended December 31, 2005. This 37% increase was primarily due to an increase in stock-based compensation charges, higher labor-related costs due to increased headcount and increased IP consulting costs, partially offset by a decrease in the amortization of acquired intangibles. Research and development expenses for the nine months ended December 31, 2006 and December 31, 2005 include stock based compensation charges of $6.3 million and $0.2 million, respectively, and amortization of acquired intangibles of $2.0 million and $2.2 million, respectively.

Research and development expenses represented 27.2% of revenues in the nine months ended December 31, 2006, and 16.8% in the nine months ended December 31, 2005.

Selling, General and Administrative

 
 
Nine Months Ended 
 
 
 
December 31,
2006
 
December 31,
2005
 
 
 
$000 
 
% of
Revenue 
 
$000 
 
% of
Revenue 
 
Selling, general and administrative
   
49,922
   
28.4
%
 
35,040
   
16.8
%

Selling, general and administrative expenses for the nine months ended December 31, 2006 were $49.9 million, compared with $35.0 million in the nine months ended December 31, 2005. This higher expense was primarily due to an increase in stock-based compensation costs of $7.2 million, and increased labor and legal costs including legal settlement costs, partially offset by a recovery on the allowance for doubtful accounts of $0.4 million. Selling, general and administration expenses for the nine months ended December 31, 2006 and December 31, 2005 include stock-based compensation charges of $7.6 million and $0.4 million, respectively.

Selling, general and administrative expenses represented 28.4% of revenues in the nine months ended December 31, 2006 and 16.8% in the nine months ended December 31, 2005.

Impairment of goodwill and intangibles

 
 
Nine Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Impairment of goodwill and intangibles
   
101,001
   
 
 
We are required to evaluate goodwill annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Due to a sustained reduction in our market capitalization plus the decline in current and projected revenue from certain customers, we determined a triggering event occurred in the quarter ending December 31, 2006 requiring management to assess the recoverability of goodwill. Impairment is tested at the reporting unit level by comparing the reporting unit’s carrying amount to its fair value. Where the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized for the amount by which the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill.
 
26

 
We have determined that the Company has one reporting unit for purposes of goodwill impairment review under SFAS 142. Upon performing the impairment test, it was found that the carrying value of goodwill exceeded its implied fair value of $84.4 million and therefore an impairment charge of $97.6 million was recorded in the current quarter. We engaged an independent valuation professional to assist with our measurement of fair value as part of the goodwill and intangible asset impairment tests. The fair value of the reporting unit was estimated using a combination of the market approach and a discounted cash flows approach.
 
Due to a decline in projected revenue, for products which incorporate technology acquired from VM Labs in fiscal 2002, we determined a triggering event occurred in the quarter ending December 31, 2006. Management assessed the recoverability of this asset by comparing its carrying amount with its estimated fair value using a discounted cash flow approach. An impairment was identified for which we recorded a non-cash impairment charge of $3.4 million prior to performing the goodwill impairment analysis.

NON OPERATING INCOME AND EXPENSES
 
Interest and Other Income
 
 
 
Nine Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Interest income
   
6,700
   
3,496
 
Other income
   
3,217
   
 
 
         
Interest and other income
   
9,917
   
3,496
 
 
Interest income includes interest earned on cash, cash equivalents and short-term investments.
 
Interest income earned for the nine months ended December 31, 2006 was $6.7 million compared with $3.5 million for the nine months ended December 31, 2005. The increase is due to the combined effects of higher average cash, cash equivalents and short-term investments and higher average interest rates during the nine months ended December 31, 2006 compared to the same period last year.

Other income includes a gain of $3.2 million on the disposal of our entire investment in the shares of Techwell, Inc. in conjunction with their initial public offering.

Provision for Income Taxes
 
 
 
Nine Months Ended 
 
 
 
December 31,
2006 
 
December 31,
2005 
 
 
 
$000 
 
$000 
 
Income tax expense
   
14,243
   
5,993
 
 
We recorded a net income tax expense of $14.2 million for the nine months ended December 31, 2006 compared to an expense of $6.0 million for the nine months ended December 31, 2005.
 
Our accounting effective tax rate typically differs from the expected statutory rates due to several permanent differences including, but not limited to, research and experimental development tax credits, stock-based compensation expense for which no tax benefits can be recognized, foreign exchange fluctuations on the U.S. dollar working capital balances of foreign subsidiaries, and differences in tax rates in foreign jurisdictions. Any net tax benefit of these items is partially offset by changes in the valuation allowance against net operating loss carry forwards. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of its deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible in the appropriate jurisdiction. Management considers projected future taxable income, uncertainties related to the industry in which Genesis operates and tax planning strategies in making this assessment.  Historically, we have recorded the majority of our valuation allowance against the tax attributes in the United States.   FASB Statement No. 109, Accounting for Income Taxes, states that forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence, such as losses in the jurisdictions to which the deferred tax asset relate.  As a result of the review undertaken in the third quarter of fiscal 2007, we concluded that it was appropriate to establish a full valuation allowance in the financial statements against the tax attributes in Canada and recorded an additional valuation allowance of $16.8 million.  In addition, we expect to provide a full valuation allowance on future tax benefits until we can demonstrate a sustained level of profitability that establishes our ability to utilize the assets in the jurisdictions to which the assets relate. Furthermore, in the near term we expect approximately $1 million of income tax expense per quarter, while we expect to incur operating losses.
 
27

 
LIQUIDITY AND CAPITAL RESOURCES
 
Since inception we have satisfied our liquidity needs primarily through cash generated from operations and sales of equity securities, initially by way of a public offering, and subsequently under our stock option and employee stock purchase plans. We believe that our existing cash balances together with any cash generated from our operations will be sufficient to meet our capital and operating requirements for the foreseeable future.
 
Periodically, we may be required to use a portion of our cash balances to increase investment in operating assets such as prepaid assets or inventory to assist in the growth of our business, or for capital assets such as land, buildings or equipment. Furthermore, because we do not have our own semiconductor manufacturing facility, we may be required to make deposits to secure supply in the event there is a shortage of manufacturing capacity in the future. While we currently have no plans to raise additional funds for such uses, we could be required or could elect to seek to raise additional capital in the future.
 
From time to time we evaluate acquisitions and investments in businesses, products or technologies that are complimentary or strategic to our business. Any such transactions, if consummated, may use a portion of our working capital or require the issuance of equity securities that may result in further dilution to our existing stockholders.
 
 
 
December 31,
2006 
 
March 31,
2006 
 
   
($ are in thousands)
 
Cash and cash equivalents
 
$
139,798
 
$
154,630
 
Short-term investments
   
53,879
   
30,749
 
 
         
Total cash, cash equivalents and short-term investments
 
$
193,677
 
$
185,379
 
 
         
Working capital
 
$
210,844
 
$
204,518
 
Current ratio
   
6.8
   
6.1
 
Receivables days outstanding
   
51
   
54
 
Inventory turnover days
   
54
   
45
 
 
At December 31, 2006, cash equivalents and short-term investments totaled $193.7 million compared with $185.4 million at March 31, 2006. Our current ratio at December 31, 2006 was 6.8 compared to 6.1 at March 31, 2006. Net cash generated from operating activities was $7.0 million for the nine months ended December 31, 2006 compared with cash generated from operations of $29.5 million for the nine months ended December 31, 2005.
 
Working capital generation of cash related primarily to the decrease in accounts receivable and the increase in income taxes payable, partially offset by a decrease in accounts payable. Accounts receivable decreased by $7.6 million from March 31, 2006 to December 31, 2006, primarily due to a decrease in revenues in the quarter. Days sales outstanding (“DSO”) decreased at December 31, 2006 to 51 days, compared to March 31, 2006. Our credit policy is to offer credit to customers only after examination of their creditworthiness. Our payment terms range from cash in advance of shipment, to payment ninety days after shipment. For the nine months ended December 31, 2006, our three largest customers accounted for 36% of revenue, compared with 35% for the nine months ended December 31, 2005. Additionally, these top three customers accounted for 34% of accounts receivable at December 31, 2006 and 46% at March 31, 2006. Inventory levels increased by 5% from March 31, 2006 to $18.0 million from $17.2 million. Average days of inventory on hand at December 31, 2006 increased to 54 days, compared to 45 days at March 31, 2006. The average inventory levels and inventory turns is impacted by a number of dynamic activities including the accuracy of customer forecasts, expected panel supplies, and pricing considerations. These activities are not necessarily an indication of what inventory turns might be in the future.
 
Net cash used in investing activities was $27.4 million during the nine months ended December 31, 2006, compared with a use of cash of $71.3 million during the nine months ended December 31, 2005. The decrease in cash used was primarily due to an increase in net proceeds received on the maturity of short-term investments and the sale of an investment during the nine months ended December 31, 2006.
 
28

 
Net cash provided by financing activities was $5.6 million for the nine months ended December 31, 2006, and $25.3 million for the nine months ended December 31, 2005. These represent funds received for the purchase of shares under the terms of our stock option and employee stock purchase plans.

Contractual Obligations
 
As of December 31, 2006, our principal commitments consisted of obligations outstanding under operating leases. These commitments include a lease for our existing corporate headquarters in Alviso, California, which expires in March 2007, and the lease for our new corporate headquarters in Santa Clara, California, which we signed in September 2006. This new lease commences on January 1, 2007, expires in January 2012, and is non-cancelable. The aggregate minimum annual payments required under our lease obligations, excluding sub-lease income, by fiscal year are as follows (in thousands):

   
 PAYMENTS DUE BY FISCAL YEAR
 
   
TOTAL
 
2007
 
2008
 
2009
 
2010
 
2011
 
Thereafter
 
                               
Operating Leases
 
$
14,076
 
$
1,750
 
$
3,908
 
$
3,769
 
$
2,003
 
$
1,704
 
$
942
 
 
Our lease agreements expire at various dates through calendar 2012.
 
Off-Balance Sheet Arrangements
 
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.
 
Capital commitments
 
We do not have any capital commitments that will have a material future effect on our financial condition.
 
29


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We are exposed to financial market risks including changes in interest rates and foreign currency exchange rates.
 
The fair value of our investment portfolio or related income would not be significantly impacted by either a 10% increase or decrease in interest rates due mainly to the short-term nature of the major portion of our investment portfolio.
 
We carry out a significant portion of our operations outside of the United States, primarily in Canada and in India and to a lesser extent China, Japan, South Korea, Singapore and Taiwan. Although virtually all of our revenues and costs of revenues are denominated in U.S. dollars, portions of our operating revenue and expenses are denominated in foreign currencies. Accordingly, our operating results are affected by changes in the exchange rate between the U.S. dollar and those currencies. Any future strengthening of those currencies against the U.S. dollar could negatively impact our operating results by increasing our operating expenses as measured in U.S. dollars. We do not currently engage in any hedging or other transactions intended to manage the risks relating to foreign currency exchange rate fluctuations, other than natural hedges that occur as a result of holding both assets and liabilities denominated in foreign currencies. We may, in the future, undertake hedging or other such transactions, if we determine it is necessary to offset exchange rate risks. Based on our overall currency rate exposure at December 31, 2006 and March 31, 2006, a near-term 10% appreciation or depreciation in the U.S. dollar relative to a pool of our foreign currencies would not have a material effect on our operating expenses or financial condition.
 
ITEM 4. CONTROLS AND PROCEDURES
 
Evaluation of disclosure controls and procedures
 
Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
 
Changes in internal control over financial reporting
 
There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
PART II: OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
In April 2001, Silicon Image, Inc. (“Silicon Image”) filed a patent infringement lawsuit against Genesis in the United States District Court for the Eastern District of Virginia (“District Court”) and simultaneously filed a complaint before the United States International Trade Commission (“ITC”). The complaint and suit alleged that certain Genesis products that contain digital receivers infringe various Silicon Image patent claims. Silicon Image was seeking an injunction to halt the sale, manufacture and use of Genesis’s DVI receiver products and unspecified monetary damages. In December 2001, Silicon Image formally moved to withdraw its complaint before the ITC, and those proceedings have terminated.
 
In July 2003, the District Court issued a memorandum opinion, followed by a final judgment in August 2003 and an amended final judgment in December 2003. In its opinion, the District Court ruled that Genesis and Silicon Image have settled their disputes based on a Memorandum of Understanding (“MOU”) signed on December 18, 2002. The District Court’s opinion states that the MOU is a binding settlement agreement and that Genesis will pay Silicon Image a monetary settlement, license fee and running royalties on all DVI and HDMI products. We recorded a provision for costs associated with this patent litigation in the year ended March 31, 2003, a portion of which was paid in escrow to the court in August 2003. An additional undisclosed amount was paid to the court as a bond in March 2004. The payments to the court have been accounted for as reductions of the related liability.
 
In January 2004, Genesis filed a notice of appeal to the United States Court of Appeals for the Federal Circuit. In April 2006, the Court of Appeals affirmed the District Court’s decision.
 
30

 
On December 21, 2006, Genesis entered into a Settlement and License Agreement with Silicon Image (the “Agreement”), granting Genesis a license to certain Silicon Image patents and settling the dispute over the interpretation of the MOU. The Agreement supersedes the MOU.
 
Pursuant to the Agreement, Genesis receives a worldwide, nonexclusive license to all Silicon Image patents with a priority date on or before September 1, 2006. In exchange for the license, Genesis agreed to pay Silicon Image a lump sum payment of $4.5 million, plus accrued and running royalties on all Genesis receiver and transmitter products compliant with the DVI 1.0 or HDMI 1.0 standards, and any minor updates to the HDMI 1.0 standard such as HDMI 1.3. The amounts of the royalties are confidential. The term of the Agreement is through September 17, 2014, unless earlier terminated pursuant to the Agreement.
 
By signing the Agreement, the parties also agreed to a mutual release of claims against each other for causes of action and liability arising prior to the effective date of the Agreement relating to the MOU, the patent litigation settled by the MOU and subsequent litigation over the interpretation of the MOU, all claims and counterclaims in such litigations, and claims of infringement of any Silicon Image licensed patent by the manufacture, use, offer for sale, sale or importation of a royalty-bearing product. However, the foregoing release does not affect Genesis’s right to challenge claims, counterclaims or defenses with respect to the patents Silicon Image asserted in the prior litigation, including noninfringement, invalidity or unenforceability, provided that any such challenge by Genesis shall only be in response to an assertion or reasonable apprehension of assertion of such patents against Genesis or the use, manufacture, importation, offering for sale or sale of Genesis products, or products incorporating a Genesis product, by Genesis’s suppliers, manufacturers, licensees, distributors, resellers or customers.
 
The Agreement also provides for a mutual covenant not to sue the other party for a period of three years.
 
Silicon Image’s license grant and covenant not to sue, as set forth in the Agreement, are assignable on a change of control of Genesis to an acquiror of Genesis, with respect to Genesis products that have been commercially produced and sold prior to the change of control date. Silicon Image’s covenant not to sue shall continue only for the remainder of the term of the covenant and only with respect to patents owned by Silicon Image existing at the time of the change of control.
 
Genesis’s covenant not to sue is assignable on a change of control of Silicon Image to an acquiror of Silicon Image, with respect to Silicon Image products that have been commercially produced and sold prior to the change of control date, and shall continue only for the remainder of the term of the covenant and only with respect to patents owned by Genesis existing at the time of the change of control.
 
The Agreement also contains audit rights, governing law and jurisdiction, and other customary terms.
 
MStar Litigation
 
Genesis filed a patent infringement complaint against MStar Semiconductor, Inc. (“MStar”) in the ITC in 2003. In August 2004, the ITC determined that MStar and the other respondents infringe Genesis’s patent, and issued an exclusion order preventing the importation of MStar’s and the other respondents’ infringing display controllers into the United States, as well as LCD monitors and boards containing these products. However, U.S. Customs declined to enforce the ITC’s exclusion order against MStar’s Tsunami (or TSU) products. In December 2004, MStar filed an appeal of the exclusion order and related ITC rulings to the Federal Circuit Court of Appeals. In May 2006, the Court of Appeals upheld the ITC’s decision in favor of Genesis. Also, in April 2006, Genesis filed a motion to enforce the exclusion order against MStar’s Tsunami products in the ITC. The ITC instituted an investigation in June 2006.
 
In October 2006, Genesis and MStar entered into an agreement to settle the litigation and to provide a license to MStar to certain Genesis patents in exchange for undisclosed running royalties. This license allows MStar to ship the infringing products into the United States. Following the settlement, Genesis and MStar jointly filed a motion to terminate the ITC proceedings, which was granted on December 6, 2006.
 
31

 
Securities Class Action Litigation
 
In November 2002, a punitive securities class action captioned Kuehbeck v. Genesis Microchip et al., Civil Action No. 02-CV-05344, was filed against Genesis, former Chief Executive Officer Amnon Fisher, and former Interim Chief Executive Officer Eric Erdman, and amended in July 2003 to include Executive Vice President Anders Frisk (collectively the “Individual Defendants”) in the United States District Court for the Northern District of California. The complaint alleges violations of Section 10(b) of the Securities and Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder against Genesis and the Individual Defendants, and violations of Section 20(a) of the Exchange Act against the Individual Defendants. The complaint sought unspecified damages on behalf of a purported class of purchasers of Genesis’s common stock between April 29, 2002 and June 14, 2002. In July 2005, the court granted Genesis’s motion to dismiss the case, with prejudice. The plaintiffs filed an appeal to the Ninth Circuit Court of Appeals. The parties signed an agreement to settle the case in March 2006. In August 2006, the court issued an order preliminarily approving the settlement. On December 8, 2006, the court issued a final judgment approving the settlement and dismissing the case with prejudice.
 
32


ITEM 1A. RISK FACTORS
 
Our quarterly revenues and operating results fluctuate due to a variety of factors, which may result in volatility or a decline in our stock price.
 
Our historical revenues and operating results have varied significantly from quarter to quarter. Moreover, our actual or projected operating results for some quarters may not meet the expectations of stock market analysts and investors, which may cause our stock price to decline. In addition to the factors discussed elsewhere in this “Risk Factors” section, a number of factors may cause our revenue to fall short of our expectations or cause fluctuations in our operating results, including:
 
·
Our ability to gain and maintain “design wins” with our customers and ramp new designs into production volumes;
 
·
Customer inventory levels and market share;
 
·
Growth rate of the flat-panel TV and LCD monitor markets;
 
·
Seasonal consumer demand for flat-panel TV, high definition TV (“HDTV”) and LCD monitors into which our products are incorporated;
 
·
Changes in the mix of products we sell, especially between our higher-priced TV/video products and our lower-priced monitor products;
 
·
Increased competition and competitive pricing pressures;
 
·
Availability and pricing of panels and other components for flat-panel TVs and LCD monitors;
 
·
Wafer costs and other product fabrication costs;
 
·
Foreign exchange rate fluctuations, research and development tax credits and other factors that impact tax rates; and
 
·
Changes in product costs or manufacturing yields or available production capacity at our fabrication facilities.
 
As a result of the fluctuation in our revenues and operating results, our stock price can be volatile, especially if our actual financial performance in a quarter deviates from the financial targets we set at the beginning of that quarter, or from market expectations.
 
A loss or a decline in sales to any of our major customers could have a significant impact on our business.
 
The markets for our products are highly concentrated. Our revenues are derived from a limited number of customers. Revenues from our largest five customers accounted for 42% of our revenues, and for our largest customer 10%, for the quarter ended December 31, 2006. We expect that a small number of customers will continue to account for a large amount of our revenues. The decision by any large customer to decrease or cease using our products would harm our business. For example, we recently lost significant TV designs at one of our largest customers. This loss is expected to negatively impact our revenue until we are able to regain designs with that customer or other customers.
 
In addition, several of our customers sell to a limited number of original equipment manufacturers (OEMs). The decision by any large OEM to decrease or cease using our customer’s products could, in turn, cause our customer to decrease or cease buying from us. Most of our sales are made on the basis of purchase orders rather than long-term agreements so that any customer could cease purchasing products at any time without penalty.

We operate in intensely competitive industries, and our failure to respond quickly to technological developments and incorporate new features into our products could have an adverse effect on our ability to compete.
 
The markets in which we operate are intensely competitive and are characterized by technological change, changes in customer requirements, frequent new product introductions and improvements, evolving industry standards and rapidly declining average selling prices. If we are unable to respond quickly and successfully to these developments, our competitive position will be harmed, and our products or technologies may become uncompetitive or obsolete.

To compete successfully, we must develop new products and improve our existing products at the same pace or ahead of our competitors. We may not be able to successfully develop and market these new products, the products we invest in and develop may not be well received by customers, and products developed and new technologies offered by competitors may affect the demand for our products. These types of events have had, and could continue to have, a variety of negative effects on our competitive position and our financial results, such as reducing our revenue, increasing our costs, lowering our gross margin percentage, and requiring us to recognize and record impairments of our assets.
 
We compete with both large and small companies, including AMD (ATI Technologies), Broadcom Corp., Intel Corp., LSI Logic Corp., Micronas Semiconductor Holding AG, Mediatek Corp., MStar Semiconductor, Inc., National Semiconductor, Novatek Microelectronics, NXP, Pixelworks, Inc., Realtek Semiconductor Corp., Renesas Technology, Silicon Image, Inc., ST Microelectronics, Inc., Techwell, Inc., Trident Microsystems, Inc., Vastview and Zoran Corporation. In addition, many of our current and potential customers have their own internally developed integrated circuit solutions, and may choose not to purchase solutions from third party merchant suppliers like Genesis. We may also face competition from start-up companies.
 
33

 
Some competitors, who may include our own customers, also include companies with greater financial and other resources than we have. Our overseas competitors have reduced cost structures that enable them to compete aggressively on price. Increased competition could harm our business, by, for example, increasing pressure on our profit margins or causing us to lose customers. Also, we have received a license from Silicon Image, Inc. for certain of their DVI and HDMI patents, and must pay Silicon Image royalties on all of our DVI and HDMI products. This agreement could hinder our ability to compete with unlicensed competitors that are not required to pay royalties on competing products.

We have had significant senior management and key employee turnover, and may not be able to attract, retain and motivate the personnel we need to succeed.
 
In order to compete, we must attract, retain and motivate executives and other key employees, including those in managerial, technical, sales and marketing positions. We have recently experienced significant turnover in our senior management team and several key employees have left the Company. For example, the position of Senior Vice President, Product Marketing is currently unfilled, and we have lost other key technical personnel. We cannot assure you that we will be able to attract and retain the senior management or other key employees we need. Competition for experienced employees in the semiconductor industry can be intense. If we cannot attract and retain the employees we need, our business could be harmed, particularly if the departure of any key employee results in a business interruption or if we are not successful in preserving material knowledge of our departing employees.
 
We do not have long-term commitments from our customers, so it is difficult for us to forecast our revenues.
 
Our sales are made on the basis of purchase orders rather than long-term purchase commitments. In addition, our customers may cancel or defer purchase orders. We provide revenue guidance and manufacture our products according to our estimates of customer demand and we have limited visibility of such demand beyond one quarter. This process requires us to make multiple demand forecast assumptions, each of which may introduce error into our estimates. If we overestimate customer demand, we may miss our revenue guidance, which could cause our stock price to drop. In addition, depending on the timing of the overestimation, including when the overestimation is corrected, could cause us to manufacture products that we may not be able to sell. As a result, we could have excess inventory, which could increase our losses. Conversely, if we underestimate customer demand or if sufficient manufacturing capacity were unavailable, we could forego revenue opportunities, lose market share and damage our customer relationships.
 
Our success will depend on the growth of the market for flat panel televisions and LCD monitors, and our customers’ share of those markets.
 
Our ability to generate revenues depends on the growth of the market for flat-panel televisions, digital televisions, LCD computer monitors, and digital televisions. Since we do not sell to every manufacturer in those markets, our revenues also depend on how well our customers perform in those markets. To the extent that our customers’ share of the flat panel television, LCD monitor or digital television markets declines or does not grow, the sales of our products will be negatively impacted. In addition, our growth will also depend upon emerging markets for consumer electronics markets such as HDTV. The potential size of these markets and the timing of their development are uncertain and will depend in particular upon:
 
·
A continued reduction in the costs of products in the respective markets;
 
·
The availability, at a reasonable price, of components required by such products (such as LCD panels); and
 
·
The emergence of competing technologies and standards.
 
These and other potential markets may not develop as expected, which would harm our business.
 
We must develop new products and enhance our existing products to react to rapid technological change and market demands.
 
We must develop new products and enhance our existing products with improved technologies to meet rapidly evolving customer requirements and industry standards. In addition, we are developing products for digital television and for the new DisplayPort interface, which are new applications for our display technology. We cannot assure you that we will be able to transition our current technology to meet the demands of the digital television market, or that a market for DisplayPort products will develop at all.
 
34

 
We need to design products for customers that continually require higher functionality at lower costs. We must, therefore, continue to add features to our products and to include these features on a single chip. The development process for these advancements is lengthy and will require us to accurately anticipate technological innovations and market trends. Developing and enhancing these products is time-consuming, costly and complex.
 
There is a risk that these developments and enhancements will be late, fail to meet customer or market specifications, and will not be competitive with other products using alternative technologies that offer comparable functionality. We may be unable to successfully develop new products or product enhancements. Any new products or product enhancements may not be accepted in new or existing markets. If we fail to develop and introduce new products or product enhancements, that failure will harm our business.
 
Our customers experience fluctuating product cycles and seasonality, which causes their sales to fluctuate.
 
Our products are incorporated into flat panel and CRT displays. Because the market for flat panel displays is characterized by numerous new product introductions, our operating results may vary significantly from quarter to quarter. Our customers also experience seasonality in the sales of their products, which affects their orders of our products. Typically, the second half of the calendar year represents a disproportionate percentage of sales for our customers due to the holiday shopping period for consumer electronics products, and therefore, a disproportionate percentage of our sales. Also, our sales in the first quarter of the calendar year may be lower as a result of the Chinese New Year holiday in Asia. We expect these sales fluctuations to continue for the foreseeable future.
 
We must sell our current products in greater volumes, or introduce new products with improved margins.
 
Average selling prices for our products have declined, in many cases significantly. When average selling prices decline, our revenues decline unless we are able to sell more units, and our gross margin dollars decline unless we are able to reduce our manufacturing and/or other supply chain costs by a commensurate amount. We therefore need to sell our current products in greater volumes to offset the decline in their ASPs, and introduce new products that have improved gross margins.
 
Our semiconductor products are complex and are difficult to manufacture cost-effectively.
 
Manufacturing semiconductor products is a complex process. It is often difficult for semiconductor foundries to achieve acceptable product yields. Product yields depend on both our product design and the manufacturing process technology unique to the semiconductor foundry. Since low yields may result from either design or process difficulties, identifying yield problems may occur well into the production cycle, when a product exists which can be physically analyzed and tested. Low yields negatively impact our gross margins and our financial results.
 
Defects in our products could increase our costs, cause customer claims, and delay our product shipments.
 
Although we test our products, they are complex and may contain defects and errors. In the past, we have encountered defects and errors in our products. Delivery of products with defects or reliability, quality or compatibility problems may damage our reputation and our ability to retain existing customers and attract new customers. In addition, product defects and errors could result in additional development costs, diversion of technical resources, delayed product shipments, increased product returns, and product liability claims against us which may not be covered by insurance. Any of these could harm our business.
 
We subcontract our manufacturing, assembly and test operations.
 
We do not have our own fabrication facilities, assembly or testing operations. Instead, we rely on others to fabricate, assemble and test all of our products. Most of our products use silicon wafers manufactured by Taiwan Semiconductor Manufacturing Corporation. If we were required to obtain silicon wafers from other manufacturers, we could experience a material increase in the price we must pay for silicon wafers. There are many risks associated with our dependence upon outside manufacturing, including:
 
·
Lack of adequate capacity during periods of excess demand;
 
·
Increased manufacturing cost or the unavailability of product in the event that manufacturing capacity becomes constrained;
 
·
Reduced control over manufacturing and delivery schedules of products;
 
·
Reduced control over quality assurance and reliability;
 
·
Difficulty of managing manufacturing costs and quantities;
 
·
Potential misappropriation of intellectual property; and
 
 
35

 
 
·
Political or environmental risks (including earthquake and other natural disasters) in Taiwan, where the manufacturing facilities are located.
 
We depend upon outside manufacturers to fabricate silicon wafers on which our integrated circuits are imprinted. These wafers must be of acceptable quality and in sufficient quantity and the manufacturers must deliver them to assembly and testing subcontractors on time for packaging into final products. We have at times experienced delivery delays and long manufacturing lead times. These manufacturers fabricate, test and assemble products for other companies. We cannot be sure that our manufacturers will devote adequate resources to the production of our products or deliver sufficient quantities of finished products to us on time or at an acceptable cost. The lead-time necessary to establish strategic relationships with new manufacturing partners is considerable. We would be unable to readily obtain an alternative source of supply for any of our products if this proves necessary. Any occurrence of these manufacturing difficulties could harm our business or cause us to incur costs to obtain adequate and timely supply of products.
 
Intellectual property infringement suits brought against us or our customers may significantly harm our business.
 
We defended and settled claims brought against us by Silicon Image, Inc., alleging that certain of our products that contain digital receivers infringe various Silicon Image patent claims. In addition, IP Innovation LLC has sued Dell Computer Corporation, LG Electronics and other companies that incorporate our products into their displays, alleging patent infringement by certain consumer and professional electronics products, including some that contain our display controller products. This lawsuit, or any future patent infringement lawsuits, could subject us to permanent injunctions preventing us from selling the accused products and/or cause us to incur significant costs, including defense costs, settlements and judgments. In addition, as a result of this lawsuit or any future patent infringement lawsuits, our existing customers may decide to stop buying our products, and prospective customers may be unwilling to buy our products.
 
Intellectual property lawsuits, regardless of their success, are time-consuming and expensive to resolve and divert management time and attention.
 
In addition, if we are unsuccessful and our products (or our customers’ monitors or televisions that contain our products) are found to infringe the intellectual property rights of others, we could be forced to do one or more of the following:
 
·
Stop selling the products or using the technology that are allegedly infringing;
 
·
Attempt to obtain a license to the relevant intellectual property, which license may not be available on commercially reasonable terms or at all;
 
·
Incur substantial costs including defense costs, settlements and/or judgments; and
 
·
Attempt to redesign those products that are allegedly infringing.
 
As a result, intellectual property litigation could have a material adverse effect on our revenues, financial results and market share.
 
We may be required to indemnify our customers against claims of intellectual property infringement.
 
From time to time, we enter into agreements with our customers that contain indemnification provisions for claims based on infringement of third party intellectual property rights. As a result, if such a claim based on our products is made against an indemnified customer, we may be required under our indemnification obligations to defend or settle the litigation, and/or to reimburse that customer for its costs, including defense costs, settlements and judgments. We may also be subject to claims for indemnification under statutory or common law. For example, we have agreed to indemnify some of our customers in connection with lawsuits or threatened lawsuits by IP Innovation LLC against Dell Computer Corporation, LG Electronics and other consumer electronics companies, alleging patent infringement by various products that contain our display controller products. This or other patent litigation and any indemnification obligations we may have could have a material adverse effect on our revenues, financial results and market share, and could result in significant payments by us that could have a material adverse effect on our financial position.
 
We may be unable to adequately protect our intellectual property. We rely on a combination of patent, copyright, trademark and trade secret laws, as well as non-disclosure agreements and other methods to protect our proprietary technologies.
 
We have been issued patents and have pending United States and foreign patent applications. However, we cannot assure you that any patent will be issued as a result of any applications or, if issued, that any claims allowed will be sufficiently broad to protect our technology. It may be possible for a third party to copy or otherwise obtain and use our products, or technology without authorization, develop similar technology independently or design around our patents. Effective patent, copyright, trademark and trade secret protection may be unavailable or limited in foreign countries. In addition, it is possible that existing or future patents, or even court rulings in our favor regarding our patents, may be challenged, invalidated or circumvented.
 
36

 
Our products require licenses of third-party technology that may not be available to us on reasonable terms, or at all.
 
We license technology from third parties that is incorporated into our products. Future products or product enhancements may require additional third-party licenses, which may not be available to us on commercially reasonable terms, or at all. We also license third-party intellectual property in order to comply with display technology standards. For example, we signed the DVI Adopters Agreement and the HDMI Adopters Agreement in order to obtain a license to those standards. However, even though we licensed the DVI technology, Silicon Image, Inc., one of the promoters of the DVI standard, sued us for allegedly infringing certain DVI patents. In December 2006, entered into a Settlement and License Agreement with Silicon Image. If we are unable to obtain third-party licenses required to develop new products and product enhancements, or to comply with applicable standards, we could be at competitive disadvantage.
 
The processes used to manufacture our semiconductor products are periodically retired.
 
As semiconductor manufacturing technologies advance, manufacturers typically retire their older manufacturing processes in favor of newer processes. When this occurs, the manufacturer generally provides notice to its customers of its intent to discontinue a process, and its customers will either retire the affected part or design a newer version of the part that can be manufactured on the more advanced process. Consequently, our products may become unavailable from their current manufacturers if the processes on which they are produced are discontinued. Our devices are mainly 0.18, 0.16 and 0.13 micron technology and the newer of these geometries will likely be available for the next two to three years. We must manage the transition to new parts from existing parts. We have commitments from our suppliers to provide notice of any discontinuance of their manufacturing processes. If we are unable to design a newer version of the part that can be manufactured on the more advanced process, we could be at competitive disadvantage.
 
Our lengthy sales cycle can result in uncertainty and delays in generating revenues.
 
Because our products are based on new technology and standards, a lengthy sales process, typically requiring several months or more, is often required before potential customers begin the technical evaluation of our products. This technical evaluation can then exceed nine months. It can take an additional nine months before a customer commences volume shipments of systems that incorporate our products. However, even when a manufacturer decides to design our products into its systems, the manufacturer may never ship systems incorporating our products. Given our lengthy sales cycle, we experience a delay between the time we increase expenditures for research and development, sales and marketing efforts and inventory and the time we generate revenues, if any, from these expenditures. As a result, our business could be harmed if a significant customer reduces or delays its orders or chooses not to release products incorporating our products. Given our customer concentration, the loss or decline in volume of one or several key customers can have a material impact on our revenue for a sustained period of time given our lengthy sales cycles.
 
A large percentage of our revenues will come from sales outside of the United States, which creates additional business risks.
 
A large portion of our revenues will come from sales to customers outside of the United States, particularly to equipment manufacturers located in South Korea, China, Europe, Japan and Taiwan. For the quarter ended December 31, 2006, sales to regions outside of the United States represented 99% of revenues. For that same period, sales to China and South Korea alone constituted 39% and 17%, respectively. These sales are subject to numerous risks, including:
 
·
Fluctuations in currency exchange rates, tariffs, import restrictions and other trade barriers;
 
·
Unexpected changes in regulatory requirements;
 
·
Political and economic instability;
 
·
Exposure to litigation or government investigations in these countries;
 
·
Longer payment periods;
 
·
Ability to enforce contracts or payment terms;
 
·
Potentially adverse tax consequences;
 
·
Export license requirements; and
 
·
Unexpected changes in diplomatic and trade relationships.
 
 
37

 
Because our sales are denominated in U.S. dollars, increases in the value of the U.S. dollar could increase the price of our products in non-U.S. markets and may make our products more expensive than competitors’ products denominated in local currencies.
 
We are subject to risks associated with international operations, which may harm our business.
 
We depend on product design groups located outside of the United States, primarily in Canada and India. We also rely on foreign third-party manufacturing, assembly and testing operations. These foreign operations subject us to a number of risks associated with conducting business outside of the United States, including the following:
 
·
Unexpected changes in, or impositions of, legislative or regulatory requirements;
 
·
Delays resulting from difficulty in obtaining export licenses for certain technology, tariffs, quotas and other trade barriers and restrictions;
 
·
Imposition of additional taxes and penalties;
 
·
The burdens of complying with a variety of foreign laws; and
 
·
Other factors beyond our control, including acts of terrorism, which may delay the shipment of our products, impair our ability to travel or our ability to communicate with foreign locations.
 
In addition, the laws of certain foreign countries in which our products are or may be designed, manufactured or sold may not protect our products or intellectual property rights to the same extent as the laws of the United States. This increases the possibility of piracy of our technology and products.
 
Our multi-jurisdictional tax structure is complex and we could be subject to increased taxation.
 
We conduct business operations in a number of countries and are subject to taxation in those jurisdictions. We develop our tax position based upon the anticipated nature and structure of our business and the tax laws, administrative practices and judicial decisions now in effect in the countries in which we have assets or conduct business, all of which are subject to change or differing interpretations. We are also subject to audit by local tax authorities which could result in additional tax expense in future periods. Any increase in our income tax expense could adversely impact on our future earnings and cash flows.
 
In addition, some of our subsidiaries provide products and services to, and may undertake significant transactions with, our other subsidiaries that are incorporated in different jurisdictions. Some of these jurisdictions have tax laws with detailed transfer pricing rules which require that all transactions with non-resident related parties be priced using arm’s-length pricing principles. International transfer pricing is a complex area of taxation and generally involves a significant degree of judgment. If international taxation authorities successfully challenge our transfer pricing policies, our income tax expense may be adversely affected.
 
The cyclical nature of the semiconductor industry may lead to significant variances in the demand for our products.
 
In the past, significant downturns and wide fluctuations in supply and demand have characterized the semiconductor industry. Also, the industry has experienced significant fluctuations in anticipation of changes in general economic conditions, including economic conditions in Asia. These cycles have led to significant variances in product demand and production capacity. They have also accelerated the erosion of average selling prices per unit. We may experience periodic fluctuations in our future financial results because of changes in industry-wide conditions.
 
A breakdown in our information technology systems could cause a business interruption, impair our ability to manage our business or report results, or result in the unauthorized disclosure of our confidential and proprietary information.
 
Our information technology systems could suffer a sudden breakdown as a result of factors beyond our control, such as earthquakes, insecure connections or problems with our outside consultants who provide information technology services to us. If our information technology systems were to fail and we were not able to gain timely access to adequate alternative systems or back-up information, this could have a negative impact on our ability to operate and manage our business and to report results in a timely manner. Also, any breach of our information systems by an unauthorized third party could result in our confidential information being made public or being used by a competitor, which could have a material adverse effect on our ability to realize the potential of our proprietary rights.
 
38

 
We may make acquisitions where advisable, and acquisitions involve numerous risks.
 
Our growth is dependent upon market growth and our ability to enhance our existing products and introduce new products on a timely basis. One of the ways we may address the need to develop new products is through acquisitions of other companies or technologies, such as our acquisitions of Sage and the assets of VM Labs. These acquisitions and potential future acquisitions involve numerous risks, including the following:
 
·
We may experience difficulty in assimilating the acquired operations and employees;
 
·
We may be unable to retain the key employees of the acquired operations;
 
·
The acquisitions may disrupt our ongoing business;
 
·
We may not be able to incorporate successfully the acquired technologies and operations into our business and maintain uniform standards, controls, policies and procedures;
 
·
We may lack the experience to enter into new markets, products or technologies; and
 
·
An acquisition we choose to pursue may require a significant amount of capital, which limits our ability to pursue other strategic opportunities.
 
Acquisitions of high-technology companies are inherently risky, and no assurance can be given that our recent or potential future acquisitions will be successful and will not adversely affect our business, operating results or financial condition. We must also maintain our ability to manage growth effectively. Failure to manage growth effectively and successfully integrate acquisitions made by us could materially harm our business and operating results.
 
We may become subject to judgments for securities class action suits.
 
We have been a defendant in a securities class action suit. In March 2006, Genesis and the plaintiff signed an agreement to settle the lawsuit, and in December 2006, the court issued a final judgment approving the settlement and dismissing the case with prejudice. However, we may be subject to future securities class action suits, which could subject us to judgments in excess of our insurance coverage and could harm our business. In addition, this kind of lawsuit, regardless of its outcome, is likely to be time-consuming and expensive to resolve and may divert management time and resources.
 
We need to continually evaluate internal financial controls against evolving standards.
 
The Sarbanes-Oxley Act of 2002 and newly proposed or enacted rules and regulations of the Securities and Exchange Commission and the National Association of Securities Dealers impose new duties on us and our executives, directors, attorneys and independent registered public accountants. In order to comply with the Sarbanes-Oxley Act and such new rules and regulations, we have evaluated our internal controls systems to allow management to report on, and our independent auditors to attest to, our internal controls. As a result, we have incurred additional expenses for internal and outside legal, accounting and advisory services, which have increased our operating expenses and accordingly reduced our net income or increased our net losses. While we have met the requirements of Section 404 including the evaluation, documentation and testing of internal controls for the year ended March 31, 2006, we cannot be certain as to the future outcome of our testing and resulting remediation actions or the impact of the same on our operations. We have an ongoing program to perform the system and process evaluation and testing necessary to comply with these requirements and we expect to continue to incur significant expenses in connection with this process. In the event that our chief executive officer, chief financial officer or independent registered public accounting firm determine in the future that our internal controls over financial reporting are not effective as defined under Section 404, investor perceptions may be adversely affected and could cause a decline in the market price of our stock. In addition, current regulatory standards are subject to change, and additional standards may be imposed.
 
General economic conditions may reduce our revenues and harm our business.
 
As our business has grown, we have become increasingly subject to the risks arising from adverse changes in domestic and global economic conditions. During times of economic slowdown, many industries may delay or reduce technology purchases. As a result, if economic conditions in the United States, Asia or Europe worsen, or if a wider or global economic slowdown occurs, reduced orders and shipments may cause us to fall short of our revenue expectations for any given period and may result in us carrying increased inventory. These conditions would negatively affect our business and results of operations. If our inventory builds up as a result of order postponement, we would carry excess inventory that is either unusable or that must be sold at reduced prices which will harm our revenues and gross margins. In addition, weakness in the technology market could negatively affect the cash flow of our customers who could, in turn, delay paying their obligations to us. This would increase our credit risk exposure, which could harm our financial condition.
 
39


ITEM 6. EXHIBITS
 
(a) Exhibits
 
EXHIBIT INDEX
 
Exhibit
Number
 
Exhibit Description
2.1(1)
 
Agreement and Plan of Merger and Reorganization, dated as of September 27, 2001, by and between Genesis Microchip Incorporated and Sage, Inc.
     
2.2(1)
 
Share Exchange and Arrangement Agreement and Plan of Arrangement by and among the Registrant, Genesis Microchip Nova Scotia Corp., and Genesis Microchip Incorporated.
     
2.3(2)
 
Agreement and Plan of Merger, dated as of March 17, 2003, among Genesis Microchip Inc., Display Acquisition Corporation and Pixelworks, Inc. (with Forms of Voting Agreements).
     
3.1(1)
 
Certificate of Incorporation of the Registrant.
     
3.2(3)
 
Amended and Restated Bylaws of the Registrant.
     
3.3(4)
 
Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock of the Registrant.
     
4.1(1)
 
Form of Common Stock Certificate of the Registrant.
     
4.2(4)
 
Preferred Stock Rights Agreement, dated as of June 27, 2002, between the Registrant and Mellon Investor Services, L.L.C., as amended on March 16, 2003.
     
10.1(5)
 
Agreement, dated January 20, 1997, between Yves Faroudja and Faroudja Laboratories, Inc.
     
10.2
 
Intentionally omitted.
     
10.3(6)*
 
Offer of employment to James E. Donegan dated June 25, 2002.
     
10.4(6)*
 
Settlement Agreement and Release with Amnon Fisher.
     
10.5(9)*
 
Offer Letter of Employment with Anders Frisk, dated February 15, 2000.
     
10.6(9)*
 
Offer Letter of Employment with Matthew Ready, dated April 12, 2000.
     
10.7(9)*
 
Offer Letter of Employment from Paradise Electronics, Inc. to Mohammad Tafazzoli, dated February 17, 1998.
     
10.8(7)*
 
Form of Change of Control Severance Agreement (as entered into between Genesis and, among others, each of Anders Frisk, Raphael Mehrbians, Tzayao Chan, and Mohammad Tafazzoli).
     
10.9(9)*
 
Separation Agreement and Release with Chandrashekar Reddy.
     
10.10(9)*
 
Consulting Agreement with Chandrashekar Reddy.
     
10.11(8)*
 
1987 Stock Option Plan.
     
10.12(8)*
 
1997 Employee Stock Option Plan.
     
10.13(21)*
 
1997 Employee Stock Purchase Plan, as last amended on August 24, 2005.
     
10.14*
 
1997 Non-Employee Stock Option Plan, as amended on February 8, 2007.
     
10.15
 
Intentionally omitted.
     
10.16*
 
2001 Nonstatutory Stock Option Plan, as amended on February 8, 2007.
     
10.17(8)*
 
Paradise Electronics, Inc. 1997 Employee Stock Option Plan.
     
10.18(8)*
 
Sage, Inc. Second Amended and Restated 1997 Stock Plan.
     
10.19(9)*
 
2001 Employee Stock Purchase Loan Plan (for non-officers).
     
10.20(9)
 
Lease Termination Agreement with 1601 McCarthy Boulevard, L.L.C. regarding premises located in Milpitas, California.

 
40

 
 
10.21(12)
 
Settlement Agreement and Release with James E. Donegan.
     
10.22(10)
 
Termination and Release Agreement, dated as of August 5, 2003, among Genesis Microchip Inc., Display Acquisition Corporation and Pixelworks, Inc.
     
10.23(11)*
 
Offer Letter with Michael Healy.
     
10.24(11)*
 
Change of Control Severance Agreement with Michael Healy.
     
10.25(11)*
 
Option Exchange Agreement with Raphael Mehrbians.
     
10.26(14)*
 
Interim CEO Employment Agreement with Eric Erdman.
     
10.27(14)*
 
Form of director and officer indemnification agreement.
     
10.28(13)*
 
2003 Stock Plan.
     
10.29(15)*
 
Form of 2000 Nonstatutory Stock Option Plan Stock Option Agreement with Nonemployee Directors.
     
10.30(15)*
 
Form of 2000 Nonstatutory Stock Option Plan International Stock Option Agreement.
     
10.31(15)*
 
Form of 2000 Nonstatutory Stock Option Plan Stock Option Agreement for China.
     
10.32(16)*
 
Amendment No. 1 to Separation Agreement and Release with Chandrashekar Reddy, dated November 10, 2004.
     
10.33(17)*
 
Offer Letter of Employment with Elias Antoun, dated November 10, 2004.
     
10.34(18)*
 
Change in Control Severance Agreement with Elias Antoun, dated November 29, 2004.
     
10.35(19)*
 
Separation Agreement and Release with Eric Erdman, dated December 3, 2004.
     
10.36(19)*
 
Consulting Agreement with Eric Erdman, dated December 3, 2004.
     
10.37(20)*
 
Separation Agreement and Release with Young Ahn, dated December 28, 2004.
     
10.38(21)*
 
1997 Employee Stock Option Plan, as amended on September 19, 2005, and form of Notice of Grant of Restricted Stock Units.
     
10.39(21)*
 
2000 Nonstatutory Stock Option Plan, as amended on September 19, 2005.
     
10.40(24)*
 
Separation Agreement and Release with Ken Murray, dated March 6, 2006.
     
10.41(22)*
 
Offer Letter with Behrooz Yadegar, dated April 11, 2006.
     
10.42(24)*
 
Fiscal Year 2007 Executive Bonus Plan, dated June 10, 2006.
     
10.43(23)*
 
Separation Agreement and Release with Tzoyao Chan, dated July 27, 2006.
     
10.43(25)*
 
Offer Letter with Hildy Shandell, dated August 30, 2006.
     
10.44(25)*
 
Change in Control Severance Agreement with Hildy Shandell, dated September 12, 2006.
     
10.45(26)
 
Lease Agreement and Lease Rider Agreement with Transamerica Occidental Life Insurance Company, dated September 18, 2006 .
     
10.46(27)*
 
Separation Agreement and Release with Raphael Mehrbians, dated October 20, 2006.
     
10.47(28)
 
Settlement and License Agreement with Silicon Image, Inc., dated December 21, 2006.
     
10.48(29)*
 
Amendment to Change of Control Severance Agreement with Anders Frisk, dated August 14, 2006.
     
21(24)
 
Subsidiaries.
     
31.1
 
Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange
Act of 1934.
     
31.2
 
Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange
Act of 1934.
 
 
41

 
 
32.1
 
Certification of Chief Executive Officer and Chief Financial Officer, as required by Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350).


(1)
 
Incorporated by reference to the Registrant’s Registration Statement on Form S-4 (File No. 333-72202) filed with the Securities and Exchange Commission on October 25, 2001, as amended.
 
   
(2)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 20, 2003.
     
(3)
 
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on July 1, 2002, as amended.
     
(4)
 
Incorporated by reference to the Registrant’s Registration Statement on Form 8-A12G filed with the Securities and Exchange Commission on August 5, 2002, as amended by the Registrant’s Statement on Form 8-12G/A filed with the Securities and Exchange Commission on March 31, 2003.
     
(5)
 
Incorporated by reference to Faroudja Laboratories, Inc.’s Form S-1 (File No. 333-32375) filed with the Securities and Exchange Commission on July 30, 1997, as amended.
     
(6)
 
Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2002.
     
(7)
 
Incorporated by reference to Registration Statement on Form S-4 filed by Pixelworks, Inc. with the Securities and Exchange Commission on April 18, 2003, as amended.
     
(8)
 
Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Securities Exchange Commission on February 21, 2002.
     
(9)
 
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the Securities Exchange Commission on June 20, 2003.
     
(10)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on August 6, 2003.
     
(11)
 
Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities Exchange Commission on February 13, 2004.
     
(12)
 
Incorporated by reference to the Registrant’s Annual Report on Form 10-K/A filed with the Securities Exchange Commission on July 29, 2003.
     
(13)
 
Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Securities Exchange Commission on October 15, 2003.
     
(14)
 
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the Securities Exchange Commission on June 10, 2004.
     
(15)
 
Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities Exchange Commission on November 9, 2004.
     
(16)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on November 15, 2004.
     
(17)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on November 19, 2004.
     
(18)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on December 3, 2004.
     
(19)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on December 8, 2004.
     
(20)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on January 3, 2005.
     
(21)
 
Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities Exchange Commission on November 8, 2005.
     
(22)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on May 10, 2006.
 
 
42

 
 
(23)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on August 1, 2006.
     
(24)
 
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on June 14, 2006.
     
(25)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on September 18, 2006.
     
(26)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on September 19, 2006.
     
(27)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on October 23, 2006.
     
(28)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on December 22, 2006.
     
(29)
 
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the Securities Exchange Commission on August 17, 2006.
     
*
 
Identifies a management contract or compensatory plan of arrangement required to be filed as an exhibit to this report pursuant to Item 14(c) of this report.
 
43

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
 
GENESIS MICROCHIP INC.
 
 
 
 
 
 
By:  
/s/ MICHAEL E. HEALY
 
Michael E. Healy
 
Chief Financial Officer
   
 
(Authorized Officer to sign on behalf of Registrant & Principal Financial Officer)
 
Date: February 9, 2007
 
44